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Summary 
Establishment and maintenance of chromatin integrity is very important for 
proper organism development. Chromatin structure is highly regulated and 
controlled by the dynamic interplay of many chromatin-associated and chromatin-
remodeling proteins. While uncontrolled alterations to chromatin structure can have 
catastrophic consequences for an organism, a certain degree of plasticity is necessary 
to enable adaptation to environmental changes. Using Drosophila melanogaster as a 
model system we undertook two projects investigating the importance of both 
epigenetic stability as well as plasticity. 
Once thought to be only stably inherited, epigenetic modifications are now 
recognized to be dynamically modulated allowing for chromatin remodeling in 
response to changes in extracellular environments. The mechanism by which 
extracellular signals, specifically in response to tissue stress, are transmitted to 
chromatin to facilitate remodeling are still unknown, however, many studies have 
implicated stress-mediated phosphorylation of chromatin proteins in this process.  
We identified 73 chromatin-associated proteins that have a greater than two-
fold increase or decrease in phosphorylation in response to stress signaling. From 
these proteins we aimed to specifically investigate the effect that stress-induced 
phosphorylation of the Polycomb group protein Posterior sex combs (Psc) has on its 
ability to maintain compacted chromatin at target genes. Psc is an essential 
component of the Polycomb Repressive Complex 1 (PRC1) and regulates cell cycle, 
differentiation and tissue growth. Intriguingly, we identified stress-induced 
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phosphorylation sites at threonine 724 and serine 727 are that are located in a 
domain of Psc essential for nucleosome binding and compaction. While we could 
characterize these phosphorylation sites, technical limitations prevented 
determination of the effect that phosphorylation of these sites has on the ability of 
Psc to compact nuclesomes in vitro and in vivo.  
While plasticity is necessary for adaptation that enables cellular survival to 
stress signaling, misregulation or mutations in chromatin-associated proteins can 
also lead to dramatic biological consequences. For example, mutations within the 
mammalian chromatin associated protein alpha-thalassemia mental retardation 
syndrome X-linked (ATRX) causes learning and memory defects and has been 
implicated in a number of cancers. ATRX contains two important chromatin-
associated domains, an N-terminal ATRX-DNMT3-DNMT3L (ADD) domain that 
binds to specific histone tail modifications and a C-terminal SNF2 nucleosome 
remodeling domain. 
A BLAST of the Drosophila melanogaster genome for the ADD and SNF2 
domains of ATRX yields two proteins, XNP and dADD1. XNP contains the SNF2 
remodeler domain while dADD1 contains the chromatin-binding ADD domain. 
Little is known about the function of these two proteins and the relationship 
between them in Drosophila. Through localization experiments, biochemical 
characterization, phenotypic analysis and behavioral assays we determined that 
these two proteins do not directly interact, however, they do function in similar 
pathways and share a number of common interaction partners. Furthermore, 
mutations in these proteins show a number of phenotypes similar to mutations in 
ATRX such as learning and memory defects and impaired transposon silencing. 
These two projects address the balance between epigenetic plasticity and 
stability. While plasticity is necessary for stress mediated repair, stability is essential 
for maintaining chromatin integrity. Together these projects highlight the complexity 
of epigenetic regulation and the necessity to further investigate both dynamic as well 
as static chromatin regulation. While I undertook two projects during my thesis, I 
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present here the work only from the characterization of dADD1 and XNP which 
investigated the importance of stable epigenetic inheritance.  
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Zusammenfassung 
Aufbau und Erhalt der Integrität von Chromatin ist essentiell für die 
Entwicklung eines Organismus. Die Struktur von Chromatin wird durch das 
dynamische Zusammenspiel vieler chromatin-assoziierter und chromatin-
remodellierender Proteine reguliert. Während unkontrollierte Veränderungen an der 
Chromatinstruktur katastrophale Folgen für den Organismus haben können, ist 
andererseits ein gewisses Maß an Plastizität notwendig, um die Anpassung an 
veränderte Umweltbedingungen zu ermöglichen. Mit Hilfe des Modelorganismus 
Drosophila melanogaster untersuchten wir im Zuge zweier Projekte die Bedeutung 
von epigenetischer Stabilität als auch Plastizität.  
Epigenetische Modifikationen galten lange Zeit als stabile Marker 
spezifischer Chromatinzustände. Mitterweile ist jedoch bekannt, dass ihre 
dynamische Regulierung Veränderungen an der Chromatinstruktur und damit die 
Reaktion auf wechselnder Umweltbedingungen ermöglicht. Die Mechanismen, 
welche extrazelluläre Signale, wie zum Beispiel Gewebestress, auf Chromatin 
übertragen sind noch weitestgehend unbekannt, jedoch wurde in mehreren Studien 
die stress-vermittelte Phosphorylierungen von chromatin-assoziierten Proteinen mit 
dieser Funktion in Verbindung gebracht.  
Im Zuge meiner Forschung, habe ich 73 chromatin-assoziierte Proteine, die 
eine mehr als zweifache Zunahme oder Abnahme der Phosphorylierung als Antwort 
auf Stresssignale aufweisen, identifiziert. Aus dieser Gruppe von Proteinen wollten 
wir die Auswirkungen stressinduzierter Phosphorylierung anhand des 
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Polycombgruppenproteins Posterior Sex Combs (Psc) analysieren und untersuchten 
spezifisch die Fähigkeit von Psc, Chromatin an Zielgenen zu kompaktieren. Psc ist 
ein wesentlicher Bestandteil des Polycomb Repressor Komplex 1 (PRC1) und 
reguliert den Zellzyklus, Gewebewachstum und Differenzierung. Wir haben 
festgestellt, dass sich die stress-induzierten Phosphorylierungen an Serin 724 und 
Threonin 727 in einer Domäne von Psc befinden, welche essentiell für die Bindung 
und Kompaktierung von Nukleosomen ist. Während wir einzelne Aspekte dieser 
Phosphorylierungsstellen charakterisieren konnten, verhinderten technische 
Einschränkungen eine tiefgreifende funktionelle Analyse dieser Phosphorylierung in 
vitro und in vivo. 
Während Plastizität für eine dynamische Anpassung an Stresssignale und 
somit für das zelluläre Überleben notwendig ist, können Deregulation oder 
Mutationen in chromatin-assoziierten Proteinen dramatische Konsequenzen haben. 
Zum Beispiel führen Mutationen innerhalb des chromatin-assoziierten Proteins 
Alpha-thalassemia mental retardation syndrome X-linked (ATRX) zu Lern- und 
Gedächtnisstörungen und wurden mit einer Reihe von Krebserkrankungen in 
Verbindung gebracht. ATRX enthält zwei wichtige chromatin-assoziierte Domänen, 
eine N-terminale ATRX-DNMT3-DNMT3L (ADD) Domäne, die spezifische 
Histonmodifikationen bindet und eine C-terminale SNF2 
Nukleosomremodellierungsdomäne. 
Eine BLAST Analyse des Drosophila melanogaster Genoms der ADD und SNF2 
Domänen von ATRX identifizierte zwei Proteine, XNP und dADD1. XNP enthält die 
SNF2-remodeler Domäne, während dADD1 die chromatin-bindende ADD-Domäne 
enthält. Über die Funktion und die Beziehung dieser beiden Proteine in Drosophila ist 
wenig bekannt. Durch Immunlokalisierungsexperimente, biochemische 
Charakterisierung, phänotypische Analysen und Verhaltenstests stellten wir fest, 
dass beide Proteine nicht direkt miteinander interagieren, aber einige zelluläre 
Funktionen, sowie eine Reihe von gemeinsamen Interaktionspartnern teilen. 
Mutationen in diesen beiden Proteinen führen zu Phänotypen, welche denen von 
ATRX ähneln, wie zum Beispiel Lern- und Gedächtnisstörungen, sowie 
Beeinträchtigungen in der DNA-Reparatur und der Transposon-Stilllegung. 
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Beide der oben beschriebenen Studien befassen sich mit der Balance 
zwischen epigenetischer Plastizität und Stabilität. Während Plastizität für 
stressinduzierte Geweberegeneration notwendig ist, ist Stabilität im Gegenzug für 
den Erhalt der Chromatinintegrität unerläßlich. Zusammenfassend widerspiegeln 
beide Projekte die Komplexität der epigenetischen Regulation und zeigen auf, wie 
wichtig es ist weiterhin dynamische als auch statische Mechanismen der 
Chromatinregulation zu untersuchen. Obwohl ich im Rahmen meiner Doktorarbeit 
an zwei Projekten gearbeitet habe, stelle ich hier nur den Teil Charakterisierung von 
dADD1 und XNP, welche die Wichtigkeit von stabiler epigenetischer Vererbung 
untersucht, vor.  
 
I n t r o d u c t i o n  
20 
1 Introduction 
1.1 Chromatin compact: the basics 
DNA is one of the most basic building blocks of life, providing the blue 
prints on how to build some of the simplest single celled organisms, such as bacteria, 
to more complex multicellular organisms such as humans. The smallest known 
genome of only 531 000 base pairs and 473 genes, belongs to an artificially generated 
Mycoplasma mycoides bacterial strain JCVI-syn3.0, that contains only the DNA and 
genes essential to provide life [1]. In comparison the human genome contains over 3 
billion base pairs and contains enough DNA in a single cell to stretch to a length of 
around 1.8 meters [2]. While exact gene numbers are not known, a 2013 estimate 
from an analysis of RefSeq data suggest that the human genome contains around 26 
000 genes [3]. In order to store so much genetic information in the small space of a 
very tiny nucleus, some organisms evolved DNA packaging systems. 
The most fundamental packaging block for DNA is the histone. Histones are 
conglomerates of four basic protein subunits, which include histone 3 (H3), histone 4 
(H4), histone 2A (H2A) and Histone 2B (H2B). Each histone contains two copies of 
the four core histone proteins, generating the so called histone octamer (reviewed in 
[4]). As histones are slightly positively charged they provide the perfect environment 
around which the DNA can wrap, with 147 bases of DNA being able to fit around a 
single histone octamer [5].  
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DNA repeatedly wraps around histones, with variable lengths of linker DNA 
between each histone (reviewed in [4]). These DNA wrapped histones are called 
nucleosomes and long strings of nucleosomes are referred to as chromatin, which 
can be further compacted. Usually, chromatin that is actively transcribed remains 
loosely packaged while silenced chromatin is highly condensed and is often 
inaccessible to transcriptional machinery. In general, loosely packaged, actively 
transcribed chromatin is referred to as euchromatin, while highly compacted, 
silenced chromatin is referred to as heterochromatin.  
Proteins that are involved in the regulation of chromatin structure are 
referred to as epigenetic regulators. These proteins have diverse functions at 
chromatin and may be involved in the maintenance or conversion of chromatin 
between active and inactive states. While many epigenetic regulators were first 
classified to play a role in either activation or inactivation of chromatin, more and 
more evidence is pointing towards these proteins having diverse, and sometimes 
opposing roles, at chromatin. For example, Heterochromatin Protein 1 a (HP1a), 
which will be discussed below, was classically defined as a chromatin silencing 
protein that is important for the formation of very compacted and silenced 
heterochromatin. However, more recently HP1a has been also shown to be 
important for gene expression (reviewed in [6]).  
The determination of active and inactive chromatin regions can be regulated 
by the addition of post translational modifications (PTM) to histone tails. These 
PTMs can include phosphorylation, methylation or acetylation, among other 
modifications, and collectively are referred to as the histone code (reviewed in [7]). 
This histone code is established by so called writer proteins that add the PTMs to 
histones. These PTMs are then recognized by so called reader proteins that bind the 
modified histone tails and can recruit other factors that help establish, maintain and 
regulate chromatin structure. These histone marks can also be removed by eraser 
proteins enabling the introduction of different histone PTMs by writer proteins, 
facilitating the conversion of chromatin between active and inactive states (reviewed 
in [8, 9]).  
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Proper regulation of chromatin is essential for the health of an organism, 
with many diseases developing as a result of epigenetic misregulation. For example, 
many different cancer types are the result of misregulation or mutations in 
epigenetic regulators (reviewed in [10, 11]). However, many other disease types such 
as neurodegenerative disorders, autoimmune disorders and cardiovascular disease 
can also be caused by aberrant epigenetic regulation highlighting the importance of 
epigenetic regulation in human health and disease (reviewed in [12]).  
1.2 Alpha-thalassemia mental retardation syndrome  
1.2.1 ATRX syndrome 
Alpha-thalassemia mental retardation syndrome (ATRX) is a human X-
linked disorder that causes mild to severe intellectual impairment in males and is 
caused by mutations within the ATRX gene. Hemizygous males display a number of 
symptoms such as alpha-thalassemia, altered facial features and genital 
abnormalities. Typically, carrier females are healthy but may display subtle signs of 
alpha-thalassemia, with the majority of carrier females showing skewed X-
inactivation, where disease carrying chromosomes are preferentially inactivated [13, 
14]. Increased frequency of mutations within ATRX have also been observed in a 
number of different cancer types including non-familial pancreatic neuroendocrine 
tumors, gliomas, sarcomas and carcinomas [15-21]. Interestingly, patients with 
ATRX syndrome do not show an increased prevalence of cancer. 
1.2.2 Chromatin function of ATRX 
Functionally ATRX is very important in the regulation of chromatin as loss or 
mutations of ATRX results in mitotic and meiotic defects, as well as alternative 
lengthening of telomeres [14, 22-24]. ATRX contains a C-terminal SNF2 chromatin 
remodelling domain and an N-terminal ATRX-DNMT3-DNMT3L (ADD) domain. 
The ADD domain of ATRX is unique in that it combinatorially recognizes and binds 
tri-methylated histone 3 lysine 9 (H3K9me3) and un-methylated histone 3 lysine 4 
(H3K4me0) [25-27]. Together, HP1a, the Human homologue of Drosophila HP1a, and 
the ATRX ADD domain recruit ATRX to pericentric heterochromatin [26].  
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ATRX has a number of functions and has been implicated in the formation 
and maintenance of heterochromatin at pericentric heterochromatin, telomeres and 
retrotransposons [28, 29]. In addition ATRX, along with its interaction partner 
Death-domain associated protein (DAXX), incorporates the histone variant H3.3 into 
ribosomal repeat sequences, telomeres and pericentric heterochromatin which is 
important for maintenance of silencing at these regions [30-32]. ATRX is also 
important for proper DNA damage response, where ATRX knock-out cells are more 
sensitive to hydroxyurea-induced replication stress [33]. Overall ATRX is very 
important for maintenance of genomic stability, and it is unsurprising that mutations 
within ATRX result in disease. Interestingly, 80% of the mapped ATRX Syndrome 
causing mutations within ATRX are located within either the ADD domain or the 
SNF2 domain, demonstrating the importance of chromatin regulation for human 
health and disease [13].  
 
 
Figure 1: Model of ATRX function at heterochromatin. 
ATRX is recruited to heterochromatin through the ADD domain binding to H3K9me3/H3K4me0 
histones as well as the interaction between HP1a. Here, ATRX works in cooperation with DAXX to 
replace H3 with histone 3 variant H3.3. Adapted from Eustermann et. al, 2011. 
 
1.2.3 The ATRX ADD domain: a unique histone recognition domain 
Located at the N-terminal region of ATRX between amino acids 169-262 is 
the specialized H3 tail binding domain, known as the ADD domain. In addition to 
ATRX the ADD domain in humans is also found in the DNA methyltransferase 
(DNMT) proteins DNMT3A and DNMT3B as well as the related but catalytically 
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inactive DNMT3L protein [34]. The ADD domain is composed of a singular GATA-
like finger domain followed by an imperfect Plant homeodomain (PHD), which 
together bind three zinc ions, resulting in the formation of a globular domain [25]. 
This globular domain forms a pocket that binds very specifically to H3 tails that are 
H3K4me0, since methylation of H3K4 decreases ADD domain binding affinity to H3 
tails [35, 36]. While the ADD domain of the DNMT proteins recognizes only the 
absence of H3K4 methylation, the ADD domain of ATRX is unique in its combined 
ability to recognize H3K9me3 together with H3K4me0, binding most efficiently to 
histones containing this combination of marks [25-27]. The amino acids important 
for recognition of H3K9me3 and H3K4me0 in the ATRX ADD domain are 
highlighted in Figure 3. 
1.2.4 SNF2 domain 
The SNF2 domain is an ATP-dependent chromatin remodeling domain that 
is capable of nucleosome sliding and re-positioning [37]. The SNF2 family can be 
divided into 24 distinct subfamilies, with many proteins being involved in 
transcriptional regulation, chromatin unwinding, DNA repair and DNA 
recombination [38, 39]. The SNF2 domain of ATRX is considered a Rad54-like 
domain based on the spacing between helicase domains [38]. Further analysis of this 
domain revealed that the SNF2 domain of ATRX is capable of nucleosome 
repositioning and that this repositioning is dependent on the presence of ATP [40]. 
Interestingly, a number of mapped disease causing mutations within the ATRX 
SNF2 domain interfere with nucleosome repositioning, suggesting that the 
nucleosome remodeling function of ATRX is essential for proper organism 
development [41]. 
1.3 Conservation in Drosophila melanogaster 
A Basic Local Alignment Search Tool (BLAST) search of the Drosophila 
genome against the ATRX ADD domain and SNF2 domain returns two results, 
dADD1 and XNP. However, unlike Human ATRX which contains both the ADD 
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and SNF2 domain in a single protein, these domains are split between the two 
proteins in Drosophila with dADD1 containing the N-terminal ADD domain and 
XNP containing the SNF2 domain (Schematic alignment Figure 2). These domains 
are highly conserved with the ADD domain of dADD1 showing a 36% sequence 
conservation (37/102 amino acids) and a 52% score of sequence identity to the 
Human sequence (Figure 3). The SNF2 domain of XNP shows a 52% sequence 
conservation (172/326 amino acids) and a 70% score of sequence identity in 
comparison to the Human sequence (Figure 3). A phylogenetic analysis of ATRX 
homologues suggested that dADD1 and XNP became two independent proteins as 
the result of a gene split in insects [42]. 
 
 
Figure 2: Alignment of Drosophila dADD1 and XNP isoforms with human ATRX. 
A BLAST search of the Drosophila genome for the ADD and SNF2 domains of human ATRX returns two 
proteins dADD1 which contains the ADD domain and XNP containing the SNF2 domain.  
Representative alignment of all annotated isoforms of dADD1 and XNP compared to human ATRX, 
including the additional protein domains such as a MADF DNA binding motif in dADD1-PB and PE 
and a motif targeted for posttranslational modifications in the long isoforms of XNP.  
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Figure 3: Amino acid sequence alignment of the ADD domain of dADD1/ATRX and the SNF2 domain of 
XNP/ATRX shows a high degree of conservation. 
Amino acid sequence alignments of the human and Drosophila ADD and SNF2 domains. These domains 
show a high degree of amino acid conservation, especially between the amino acids necessary for 
H3K9me3 recognition in the ADD domain and within mapped disease causing mutations.  
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Interestingly, the majority of the mapped disease causing mutations within 
ATRX show either full or partial conservation within Drosophila, suggesting these 
amino acids are important for chromatin domain function in multiple species (Figure 
3, red stars). This conservation is also very apparent within the amino acids of the 
ADD domain that are necessary for H3K9me3 recognition, with 8/10 of these amino 
acids showing full or partial conservation (Figure 3, purple stars). However, the 
conservation between the dADD1 and ATRX ADD domain it not as strong between 
the amino acids involved in H3K4me0 recognition, with only 1/4 amino acids being 
partially conserved (Figure 3, blue stars). 
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2 Aim of this study 
Cellular loss of ATRX function results in mitotic and meiotic defects, altered 
DNA damage response and impaired transposon silencing. ATRX contains two 
important chromatin associated domains, an N-terminal ATRX-DNMT3-DNMT3L 
(ADD) domain and a C-terminal SNF2 chromatin remodeler domain. The ADD 
domain together with the HP1a interacting domain, is important for the recruitment 
of ATRX to heterochromatin and mediate the chromatin regulatory function of 
ATRX. The majority of mapped disease causing mutations fall within either the 
ADD or SNF2 domain, highlighting the importance of proper chromatin architecture 
for human health and development.  
Since mutations in ATRX cause ATRX syndrome and have been linked to 
different cancer types, we sought to understand if Drosophila could be used as a 
model system to further investigate the the molecular mechanisms of ATRX. To do 
so we aimed to undertake an analysis of the Drosophila ATRX homologues dADD1 
and XNP to determine if these proteins show function conservation to ATRX. 
Through localization experiments, biochemical characterization, phenotypic analysis 
and behavioral assays this project aimed to better understand the cellular and 
organismal functions of these two proteins and to investigate the relationship 
between them.  
To analyze functional conservation with human ATRX, we sought to test 
dADD1 and XNP mutants for known ATRX mutant phenotypes including defects in 
learning and memory, double-strand DNA repair response and transposon 
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silencing. In addition, we sought to characterize the interaction between dADD1 and 
XNP and to identify new interaction partners of both proteins through co-
immunoprecipitation and mass spectrometry, as well as immunolocalization 
experiments. The identification of new interaction partners was expected to provide 
new leads into which biological processes not only XNP and dADD1 but also human 
ATRX proteins may be involved in.  
Many people worked on this project and contributed ideas, methods, lab 
space and time at the bench. Those directly involved in this project include: Dr. 
Anne-Kathrin Classen, Dr. Axel Imhof, Dr. Andreas Thomae, Dr. Ignasi Forne, Dr. 
Annette Schenck, Dr. Michaela Fenckova, Isabelle Grass, Kathrin Bergel, Nikolai 
Hörmann, Ian Will, Marco La Fortezza and Sarah Schäfer. For those who helped 
perform the experiments their names appear in the figure legends.  
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3 Results 
3.1 Biochemical characterization of dADD1 
3.1.1 dADD1-PA is a 250kD protein 
At the beginning of this project dADD1 was an uncharacterized and 
unnamed protein known to us by its CG identifier CG8290. As little was known 
about this protein we first began to investigate the biochemical characteristics of 
dADD1, using tools established by Dr. Andreas Thomae. These reagents included a 
cloned construct of the long isoform of dADD1-PA and a stable cell line expressing 
C-terminally Flag/HA-tagged dADD1-PA under the control of an inducible pMT 
promoter and an antibody raised against an N-terminal sequence common to all 
isoforms. On western blots of stable cell extracts overexpressing the long isoform 
dADD1-PA, the dADD1 antibody detects a band that is 250 kD in length, which is 
consistent with the molecular weight protein identified using an HA antibody 
(Figure 4 B). This molecular weight was much larger than the predicted weight of 
dADD1-PA of 130 kD (Figure 4 A).  
To confirm this molecular weight increase we tested brain and ovary cell 
lysate extracts from a dADD1-BioTAP line as well as ovary cell lysates from a 
dADD1 GFP trap line (dADD1endoGFP). The dADD1-BioTAP fly line contains a gDNA 
bacmid clone inserted onto the third chromosome with a C-terminal protein A tag 
that only tags the long isoform of dADD1 (Figure 4 A, arrow BioTAP). The 
dADD1endoGFP was generated through random insertion of a MiMIC construct 
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containing GFP-Streptavidin-Flag (GFP-ST-F) tags as well as acceptor and donor 
splice sits, inserted into the endogenous dADD1 locus at a sequence common to all 
isoforms, and should therefore be spliced into all isoforms (Figure 4 A, arrow MiMIC 
GFP-ST-F). In both the dADD1-BioTAP and the dADD1endoGFP a high molecular 
weight protein around 250 kD was observed, consistent with our observation from 
stable cell lines expressing the long isoform of dADD1, indicating that the long 
isoform of dADD1 is actually a 250kD protein (Figure 4 C and D).  
 
 
Figure 4: The long isoform of dADD1 is much larger than predicted and is the dominantly expressed 
isoform in ovaries. 
dADD1-PA is much larger than predicted. A) There are three Flybase annotated isoforms of dADD1, 
and a fourth isoform identified by Lopez-Falcon et.al, 2014, that is similar to dADD1-RB but retains the 
fifth intron. Arrows indicate tag insertion of MiMIC cassette (MiMIC GFP-ST-F) into all isoforms of 
dADD1 and BioTAP insertion that tags only the long isoform with a biotin and Protein A tag. Genomic 
deletion of P-element excision mutant dADD12 is indicated by grey box, outlining approximate length 
and location of the deletion. B) Overexpression of the long isoform of dADD1-PA in stable S2DRSC 
cells. Construct contains a dual C-Terminal Flag/HA tag and is detected by both an HA antibody as 
well as a dADD1 specific antibody. The dADD1-PA-Flag/HA construct runs around 250kD, much 
larger than the 130kD predicted weight. Control are wild type S2DRSC cells. C) BioTAP tagged 
dADD1-PA is expressed in ovaries, larval brains as well as female and male adult brains. The BioTAP 
dADD1-PA protein has a molecular weight of about 250kD. Control flies are w1118 D) dADD1 MiMIC 
construct (dADD1endoGFP) is expressed in ovaries. GFP antibody detects a very strong band at over 
250kD but also lower molecular weight bands that correspond to the other isoforms of dADD1 plus the 
additional MiMIC tag. The long isoform of dADD1 appears to be the most dominantly expressed 
isoform in ovaries. Control are ovaries from HP1a GFP flies. Western blot in C performed by Ian Will 
and western blot in D performed by Sarah Schäfer. 
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The expression of dADD1 in different tissue was tested using the dADD1-
BioTAP line and revealed that dADD1-PA is expressed in both female and male 
adult brains, in larval brains and in ovaries. Analysis of the dADD1endoGFP line also 
revealed that, at least in ovaries, this high molecular weight dADD1-PA isoform is 
the most dominantly expressed isoform, although smaller molecular weight bands 
corresponding to the other isoforms are also present. These results are in contrast to 
previous publications that suggest dADD1 isoforms are equally expressed and run 
at their predicted molecular weights [42].  
To understand why dADD1-PA has a molecular weight almost double the 
predicted weight we tested whether the long isoform was a dimer by boiling stable 
cell lysates in high concentrations of b-mercapotethanol (BME) for up to 5 hours. 
BME is a reducing agent that disrupts di-sulphide bonds between cysteine residues, 
dissolving tertiary and quaternary protein structures. Boiling cell lysates in 10% 
BME resulted in no change in the molecular weight of dADD1-PA when compared 
to normal western blot boiling conditions with 1% BME for 5 minutes (Figure 5 A). 
The same results were obtained when samples were boiled in 10% DTT, another 
reducing agent similar to BME re-confirming that dADD1-PA does not form a dimer 
(data not shown).  
Since the molecular weight increase was not caused by protein dimerization, 
we then tested if dADD1-PA contained PTMs that added to the total weight of the 
protein. We tested for the addition of Ubiquitin, O-linked N-acetylglucosamine (O-
GlcNAc) and and Poly-(ADP Ribose) (PAR). Classically defined as a PTM that marks 
proteins for proteosomal degradation, ubiquitin is now known to function in a 
number of different cellular processes such as cell signaling and transcriptional 
regulation. A single ubiquitin protein weighs 8.5 kD with ubiquitin being added to 
proteins either as a single molecule or as a poly-ubiquitin chain, where multiple 
ubiquitin proteins are covalently linked [43]. O-GlcNAc is a sugar molecule that is 
added to serine and threonine residues of proteins by the enzyme O-linked N-
acetylglucosaminyl transferase or OGT. Addition of O-GlcNAc to a protein has 
many different biological functions and is known to be involved in transcriptional 
regulation as well as regulation of protein-protein interactions [44]. PAR is another 
 
R e s u l t s  
33 
protein PTM that is mainly triggered by DNA damage responses and can help to 
initate programmed cell death. Many nuclear proteins have been shown to be PAR 
modified including many DNA associated proteins including histones [45].  
By western blot dADD1 appears to be ubiquitinated but contains no O-
GlcNAc or PAR modifications (Figure 5 B). Since a known interaction partner of 
dADD1 contains a RING E3 ubiquitin ligase domain we tested if this protein, called 
Bonus, was the ubiquitin ligase of dADD1. To do so we knocked down Bonus in 
dADD1 stable cells and compared ubiquitination levels of dADD1 after Bonus 
knockdown (Figure 5 C). After RNAi knockdown Bonus was not detectable in the 
cell lysate, indicating that the knockdown was efficient (Figure 5 C, +RNAi Bonus). 
However, we observed no decrease in total ubiquitination of dADD1 between the 
control and the Bonus RNAi samples indicating that Bonus is not the primary 
ubiquitin ligase of dADD1. Pull downs of dADD1 were also tested for ubiqutinated 
peptides by MS, but no ubiquitin modified peptides were identified (data not 
shown). It is therefore difficult to definitively conclude that dADD1 is ubiqutinated, 
and more work should be done to determine if ubiqutination does indeed contribute 
to the increased molecular weight of dADD1-PA. 
 
 
Figure 5: Increased molecular weight of the long dADD1 isoform is not the result of dimerization, O-
linked N-acetylglucosamination or Poly-ADP ribosylation. dADD1 may be ubiqutinated but the RING 
domain containing protein Bonus is not the primary ubiquitin ligase of dADD1. 
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Experiments were performed in a stable S2 cell line expressing the long dADD1 isoform. A) dADD1 
does not form a dimer. Boiling of stable cell lysates in 10% BME for up to 5 hours does not decrease the 
molecular weight of the protein when compared to the normal western blot preparation conditions of 
1% BME for 5 minutes. B) dADD1 is ubiquitinated. Pull downs of dADD1 from stable cells show that 
dADD1 is ubiquitinated but is not O-GlcNAc or PAR modified. Control sample of HA pull downs from 
S2DRSC cells. C) Bonus is not the primary ubiquitin ligase of dADD1. Knock down of bonus, a known 
interaction partner of dADD1 that contains a E3 ubiquitin ligase RING domain, does not decrease 
ubiquitination of dADD1. bonus is efficiently knocked down by RNAi, but RNAi treated samples show 
no decrease in total cellular dADD1, tubulin or HP1a levels.  
3.2 Relationship between dADD1 and XNP 
A phylogenetic analysis of ATRX homologues suggested that dADD1 and 
XNP became two independent proteins as the result of a gene split in insects [42]. 
Since dADD1 and XNP are the Drosophila homologues of mammalian ATRX we 
sought to determine whether these proteins function together or in similar 
pathways. To do so we looked at tissue level and subcellular localization, 
biochemical interactions and molecular phenotypes caused by loss or overexpression 
of these proteins.  
Previously published reagents for XNP were kindly provided by the lab of 
Dr. Kami Ahmad. These included an antibody against all isoforms of XNP as well as 
two deletion mutant alleles for XNP, XNP403 and XNP406 [46]. These XNP mutants 
were generated by P-element excision which resulted in the loss of a large genomic 
fragment from the 5’ end of XNP, removing the start codon and the majority of the 
first exon from all isoforms (Figure 6 A). We tested the XNP antibody for specificity 
by staining XNP403 and XNP406 mutant ovaries with the XNP antibody (Figure 6). We 
observed a complete loss of XNP staining in the nucleus of homozygous mutant 
ovaries, verifying antibody specificity and also that the XNP403 and XNP406 alleles are 
homozygous null alleles.  
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Figure 6: XNP403 and XNP406 mutants are null mutants as staining with XNP antibody does not detect 
XNP in either mutant. 
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Testing of XNP mutants and antibodies. A) Gene structure of XNP. XNP has four isoforms with XNP-
RA/B and XNP-RD/C sharing the same coding sequence but different 5’ and 3’ UTR’s. Genomic 
deletions from two p-element excision mutants, XNP403 and XNP406, are outlined by the grey box 
indicating approximate size and location of the deletions. b-g) Antibody stainings of XNP in Iso31 
control and homozygous XNP403 and XNP406 mutant ovaries. The XNP antibody signal strongly 
overlaps with the DNA signal in Iso31 control ovaries. This staining is lost in both the XNP403 and 
XNP406 mutant ovaries. Microsocopy images produced by Kathrin Bergel. 
 
An excision mutant of dADD1, dADD12, was generously provided by the lab 
of Dr. Mitzi Kuroda, who also provided the BioTAP line discussed in section 3.1.1 
dADD1-PA is a 250kD protein. The excision mutant contains a genomic deletion of 
dADD1 that removes almost the entire coding sequence of dADD1-RB and RE while 
deleting all but the last exon from dADD1-RA (Figure 4 A). Antibodies specific to 
dADD1 that recognizes an N-terminal epitope common to all dADD1 isoforms were 
provided by Dr. Andreas Thomae. From these antibodies a single hybridoma clone, 
8F11, proved to be specific to dADD1 as we observed a complete loss of staining in 
homozygous dADD12 mutant ovaries, and simultaneously observed a significant 
overlap in staining with dADD1endoGFP (Figure 7).  
 
 
Figure 7: Confirmation of dADD1-8F11 antibody, dADD1endoGFP fly line and dADD12 homozygous fly 
line. 
a) dADD1endoGFP and dADD12 homozygous mutants stained with DNA dye DAPI and dADD1-8F11 
(dADD1) antibody. Homozygous dADD12 ovaries show complete lack of staining with dADD1 
antibody. dADD1endoGFP localization overlaps with DAPI bright AT rich DNA regions representing 
heterochromatin. b) dADD1-8F11 antibody and dADD1endoGFP show significant overlap at chromatin, 
with a strong enrichment at heterochromatin and a diffuse staining over euchromatin. Stainings 
performed by Nikolai Hörmann 
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These tools, and others, were used to help dissect the relationship between 
dADD1 and XNP in the following sections. 
3.2.1 dADD1 and XNP are expressed in both neurons and glia 
Both dADD1 and XNP are highly expressed in embryonic and larval central 
nervous system as well as in neurons and glia in adult brains [47, 48] (Figure 8 a and 
b). Since loss of ATRX in humans causes intellectual impairment, we sought to 
determine if Drosophila could be used as a model to elucidate the mechanisms that 
underlie learning disabilities in human ATRX patients. To do so we employed a 
well-established assay for studying learning and memory defects in Drosophila that 
measures habituation to a light-off stimulus that induces startle-jump responses [49].  
Previously characterized mutants for both dADD1 (dADD12) and XNP 
(XNP403 and XNP406) were isogenized over 7 generations to an Iso31 background and 
tested in habituation assays. Since habituation assays rely on the measurement of 
startle-jump response to repetitive light-off stimulus, flies need to be tested for 
fitness as reduced fitness can cause false positives in this assay when the lack of 
startle response results from flies being physically unable to jump. We first tested 
homozygous dADD12 and heterozygous dADD12, XNP403 and XNP406 mutants for 
fitness. Homozygous XNP mutants were not tested for fitness or habituation as XNP 
homozygous mutant lines could not be maintained and too few progeny eclosed 
from balanced crosses. 
Fitness was tested by repeatedly subjecting the flies to a prolonged light off 
stimulus that should cause a continued startle response in wild type flies. Of all the 
mutants tested none of them showed a significant decrease in their fitness in 
comparison to the wild type (Figure 8 C). Although it appears the dADD12 
homozygous mutants have a slightly decreased fitness, this change is not significant 
and has a P-Value 0.25. As the heterozygous XNP403 and XNP406 flies as well as 
dADD12 heterozygous mutants did not display a reduced fitness, dADD1 
homozygous as well as dADD1 and XNP heterozygous mutant lines were further 
tested in habituation assays to test how long it takes for flies to learn to stop jumping 
in response to a light-off stimulus. 
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Figure 8: dADD1 and XNP are present in neurons and glia of the adult brain. Loss of these proteins 
results in learning and memory defects in adults. 
dADD1 and XNP are found within neurons and glia and are important for brain function. a) Staining of 
adult dADD1endoGFP brains with a neuronal marker (elav) and glial marker (Repo) shows that dADD1 is 
present in both neurons and in glia of the adult brain. b) Adult brain staining of brains expressing a 
neuronal marker nSyb GFP stained for XNP and Repo to mark glia. XNP is found in both neurons and 
in glia of the adult brain. C) Fitness assays of heterozygous XNP403 and XNP406 mutants as well as 
dADD12 heterozygous and homozygous mutants. Flies were subjected to repetitive light off stimulus 
that induces continued startle response in wild type (w1118) flies. Calculated P-Values for mutants are all 
above 0.05 indicating mutant fitness is not significantly different than the wild type. D) Habituation 
assay measuring how quickly wild type (w1118) and mutant flies learn to not startle in response to light 
off stimulus. Heterozygous XNP mutants as well as dADD1 homozygous mutants show a slowed 
learning response as indicated by an increase in the mean TTC. P-Values denote significance in 
comparison to wild type response. Brain stainings were performed by Nikolai Hörmann. Fitness and 
habituation assays were performed by collaborators at the Radboud University Nijmegen Medical 
Center in the lab of Dr. Annette Schenck. 
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Startle response to a light-off stimulus was tested 50 times using a 15 
millisecond light-off pulse followed by 1 second of light-on. The light-off pulses are 
frequent enough that eventually wild type flies stop jumping as they learn that the 
stimulus poses no threat. Flies met the criteria of being habituated when they did not 
startle for 5 consecutive light-off pulses and the number of light pulses needed to 
reach the criteria for habituation were counted as the trials to criteria (TTC). The 
XNP heterozygous mutants as well as the dADD1 homozygous mutants displayed a 
slowed habituation response in the habituation assays, indicated by an increase in 
mean TTC, while the dADD1 heterozygotes showed a speed of habituation 
comparable to wild type flies (Figure 8 D). This indicated that a loss of dADD1 or 
XNP causes learning and memory defects in flies, similar to mutations of ATRX in 
humans. 
3.2.2 dADD1 but not XNP is enriched in the oocyte germinal vesicle 
modENCODE RNA-Seq data showed that, in addition to the larval central 
nervous system, both dADD1 and XNP are highly expressed in ovaries [47]. Using 
the XNP and dADD1 antibodies we stained ovaries of fattened, mated females to 
determine if dADD1 and XNP proteins are present in egg chambers, and in which 
cells of the developing egg chamber they localize.  
Drosophila ovaries contain both germline and somatic tissue. The germline is 
composed of both nurse cells and a single oocyte, that are encapsulated by somatic 
follicle cells. In late stage egg chambers, the oocyte is the largest cell and contains the 
oocyte nucleus contained in a structure called the germinal vesicle. Through 
antibody stainings we determined that both XNP and dADD1 are present in the 
germline nurse cells as well as the germinal vesicle (Figure 9). While XNP was also 
present in the somatic follicle cells, the dADD1 antibody did not detect any signal in 
these cells. However, we were able to detect low levels of dADD1 in the follicle cells 
of dADD1endoGFP ovaries (Figure 7).  
Interestingly we observed a striking difference in the enrichment of dADD1 
and XNP in the germinal vesicle. While the intensity of the XNP signal is similar 
between the germinal vesicle, nurse cells and follicle cells, the intensity of the 
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staining of dADD1 in the germinal vesicle is significantly higher than the staining of 
nurse cell chromatin. This indicates that dADD1 may be selectively enriched into the 
germinal vesicle, suggesting that dADD1 may be important for chromatin 
establishment during the first embryonic cellular divisions.  
 
 
Figure 9: dADD1 is selectively enriched in the oocyte germinal vesicle. 
Staining of both XNP and dADD1 using protein specific antibodies in HP1a GFP ovaries. HP1a GFP, 
XNP and dADD1 localize to nurse cell chromatin and all are pre-packaged into the oocyte germinal 
vesicle, with dADD1 being selectively enriched. HP1a GFP and XNP but not dADD1 show staining in 
the somatic follicle cells surrounding the oocyte. Stainings performed by Kathrin Bergel. 
 
During the first mitotic cellular divisions following fertilization, the zygotic 
genome is inactive and is not actively transcribing genes. In Drosophila there are two 
waves of zygotic genome activation, the first occurring at mitotic cycle 8 and the 
second at mitotic cycle 14, however, until this point the zygote must rely on 
maternally deposited mRNAs and proteins to establish the early chromatin 
landscape [50]. dADD1 and XNP homozygous mutants are viable, indicating that 
these proteins are not essential, but may assist in the establishment of early 
embryonic chromatin. Their non-essential role in this process may be conceptually 
similar to the observed role that ATRX plays in transposon silencing, where 
transposons in homozygous ATRX mutant cells are silenced, but at a much slower 
rate than in wild type cells [29].  
3.2.3 dADD1 and XNP show distinct chromatin localization patterns at 
nurse cell chromatin  
To study the chromatin localization of dADD1 and XNP we chose to look at 
the polytenized chromatin of egg chamber cells. When a developing egg leaves the 
stem cell niche of the germarium, the cells divide until the egg chamber contains 
around 800 follicle cells, 15 nurse cells and a single oocyte containing the germinal 
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vesicle (see schematic in Figure 10). At this point, around stage 6, the cells stop 
dividing and both somatic follicle cells as well as germline nurse cells begin to 
endoreplicate, causing polytenization of egg chamber chromatin. The highly 
replicated genome enables simple visualization of chromatin protein localization.  
 
 
Figure 10: Schematic of egg chamber morphology from stage 6 to stage 10. 
Drosophila egg chambers contain both somatic tissue as well as germline tissue. The somatic follicle cells 
surround the germline cells which consist of nurse cells and the oocyte. Within the oocyte is the 
germinal vesicle where the maternally contributed DNA is stored. Until stage 6 cells undergo cell 
division until the egg chamber contains approximately 800 follicle cells, 15 nurse cells and a single 
oocyte. At this point both the somatic follicle cells as well as the nurse cells begin to endoreplicate 
causing chromatin polytenization. The majority of images in this thesis are from egg chambers between 
stages 6-10.  
 
Using this system, we visualized the subnuclear localization patterns of 
dADD1 and XNP by looking at co-localization in flies also expressing a GFP tagged 
HP1a construct. HP1a is enriched at heterochromatin and is commonly used as a 
heterochromatin marker. For simplicity of discussion in this thesis, I refer to any 
region enriched with HP1a or associated marks (H3K9me3 and H3.3, discussed in 
the next paragraphs) as heterochromatin and all other chromatin regions as 
euchromatin. We found that XNP uniformly distributed across nurse cell chromatin 
and showed no enrichment at heterochromatin or euchromatin (Figure 11 b). 
dADD1 showed a widespread distribution across euchromatin similar to XNP, but 
additionally displayed a strong enrichment at heterochromatin, as determined by co-
localization with HP1a GFP (Figure 11 a).  
We additionally looked at co-localization with other chromatin proteins and 
components known to be associated with dADD1 or XNP (See section 3.4 Other 
interaction partners of dADD1 and XNP). These included histone variant H3.3, 
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histone modification H3K9me3, HP1b and Bonus. H3.3 is a known interactor of 
mammalian ATRX, with ATRX and interaction partner DAXX incorporating H3.3 
into telomeres and transcribed heterochromatin repeat sequences [30, 31]. In 
mammalian systems H3.3 has been shown to be incorporated into both euchromatin 
and heterochromatin and is associated with both actively transcribing as well as 
silenced chromatin [32, 51, 52]. Furthermore, it has been suggested that XNP is one 
of two proteins in Drosophila capable of replication-independent nucleosome 
replacement of H3.3 [53]. Stainings of nurse cell chromatin show that H3.3 is present 
in euchromatin, but also shows enrichment at heterochromatin as determined by 
strong co-localization with HP1a (Figure 11 c). This indicates, that at least in 
Drosophila, H3.3 is enriched at heterochromatin, and in further experiments 
chromatin regions enriched for H3.3 were superficially classified as heterochromatin.  
The histone modification H3K9me3, which is bound by the chromo-domain 
of HP1a and by the ADD-domain of dADD1 and ATRX, unsurprisingly showed 
very specific staining at heterochromatin. H3K9me3 significantly overlaps with 
HP1a and in further experiments was also used as a marker for heterochromatin 
(Figure 11 d).  
HP1b is a heterochromatin protein 1 family member that has been implicated 
in transcriptional activation of euchromatic gens [54]. As reported previously, we 
found in nurse cell chromatin stainings that HP1b appears to occupy chromatin 
domains distinct from HP1a, primarily staining euchromatic regions and showing 
little enrichment at heterochromatin [55] (Figure 11 e). Localization of the dADD1 
interaction partner Bonus was also tested, with Bonus showing a uniform staining 
across euchromatin, and in many instances was excluded from HP1a rich 
heterochromatin. 
 
 
R e s u l t s  
43 
 
Figure 11: dADD1, H3.3 and H3K9me3 co-localize with HP1a GFP at heterochromatin, while XNP, 
HP1b and Bonus show uniform staining across nurse cell chromatin.  
Localization of dADD1, XNP, H3.3, H3K9me3, HP1b and Bonus to nurse cell chromatin compared to 
localization of HP1a GFP. a) dADD1, stained with the dADD1 antibody, shows significant overlap with 
HP1a GFP, showing enrichment at heterochromatin, and a diffuse staining over euchromatin. b) XNP 
shows no enrichment at heterochromatin, but displays a uniform staining across nurse cell chromatin. 
c) Histone variant H3.3 shows strong co-localization and enrichment with HP1a GFP at 
heterochromatin, but also stains euchromatin. d) Histone 3 modification H3K9me3 shows significant 
co-localization with HP1a GFP at heterochromatin. e) HP1b displays a uniform staining across 
chromatin, and appears to occupy distinct chromatin regions from HP1a GFP. f) Bonus, a known 
dADD1 interactor, localizes to euchromatin and occupies distinct chromatin regions from HP1a GFP.  
 
We observed similar localization patterns of dADD1 and XNP to chromatin 
in HELA Kyoto cells where dADD1 but not XNP is highly enriched at H3K9me3-rich 
chromatin (Figure 12 a and b). The localization of dADD1 to H3K9me3-rich regions 
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in HELA cells supports previous in vitro data showing the ADD domain has a 
conserved H3K9me3 binding function, and suggests that binding of the ADD 
domain to H3K9me3 may recruit dADD1 to chromatin [56]. Expression of XNP in 
HELA cells results in nuclear localization and a relatively uniform staining across 
chromatin, although some chromatin regions showed increased XNP localization. A 
few of these XNP domains overlapped with H3K9me3 rich chromatin domains but 
the enrichment was significantly reduced in comparison to dADD1. Unfortunately, 
co-transfection experiments of dADD1 and XNP in HELA cells were unsuccessful, 
and through these experiments we could not determine if dADD1 is capable of 
recruiting XNP chromatin.  
 
 
Figure 12: dADD1 is recruited to H3K9me3 rich regions in HELA Kyoto cells. 
Overexpression of dADD1-GFP and XNP-GFP constructs in human cancer cell derived HELA Kyoto 
cells. a) dADD1-GFP shows nuclear localization and strongly co-localizes with H3K9me3 rich 
chromatin in HELA cells. b) XNP-GFP localizes to the nucleus, and shows a relatively uniform staining 
across chromatin. There is some enrichment of XNP to specific chromatin regions, with few of these 
enriched regions co-localizing with H3K9me3 rich chromatin. 
 
3.2.4 dADD1 and XNP are recruited independently to chromatin 
To better understand if the localization of dADD1 and XNP to chromatin was 
dependent on the presence of the other protein we stained homozygous dADD12 and 
XNP403 egg chambers with dADD1 and XNP antibodies. Wild type control ovaries in 
the majority of the imaging experiments contained a ubiquitously expressed RFP 
tagged shotgun (shg) construct labeled shgRFP. Shg encodes fly E-cadherin, which 
localizes to cell-cell contacts and enables easy identification of wild type control 
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ovaries. Interestingly, localization of either dADD1 or XNP protein did not change in 
the corresponding mutants when compared to localization in control ovaries, 
indicating that dADD1 and XNP are recruited to chromatin independently of one 
another (Figure 13).  
 
 
Figure 13: Loss of dADD1 or XNP does not affect the chromatin localization of the other protein. 
Staining of dADD1 and XNP in dADD12 and XNP403 homozygous mutants. XNP shows a normal nurse 
cell chromatin staining in dADD12 homozygous mutants when compared to shgRFP controls. dADD1 
shows normal staining in XNP403 homozygous mutants when compared to shgRFP controls, with 
enrichment at heterochromatin. H3.3 deposition at heterochromatin is unchanged by loss of either 
dADD1 or XNP.  
 
Similarly, overexpression of dADD1 in somatic follicle cells of the egg 
chamber did not increase the recruitment of XNP to heterochromatin, but did 
increase the localization of other associated proteins at heterochromatin (Figure 14 a 
and b, Discussed in sections 3.5.3 and 3.5.4). Furthermore, overexpression of XNP in 
follicle cells did not increase the incorporation of dADD1 into euchromatin or 
heterochromatin (Figure 14 c and d). Taken together, loss and overexpression data 
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indicates that dADD1 and XNP are recruited independently to chromatin, and do 
not rely on the presence of the other protein for chromatin localization.  
 
 
Figure 14: Overexpression of dADD1 or XNP does not increase the chromatin recruitment of the other. 
dADD1 and XNP do not recruit one another to chromatin. a) XNP shows a uniform staining across 
follicle cell chromatin in control shgRFP ovaries b) A dADD1-GFP construct that is specifically 
expressed in egg chamber follicle cells using the TJGLA4 driver is recruited to heterochromatin but 
XNP is not recruited to dADD1-GFP rich heterochromatin. Note localization of the dADD1-GFP 
construct to the nucleolus. c) Endogenous dADD1 antibody does not detect dADD1 in follicle cells of 
shgRFP control ovaries. d) Overexpression of an XNP-HA construct specifically in egg chamber follicle 
cells using the TJGAL4 driver results in a general recruitment of XNP-HA to follicle cell chromatin. 
dADD1 recruitment to chromatin is not increased in XNP-HA overexpressing cells.  
3.3 Biochemical and genetic interaction between dADD1 and 
XNP 
3.3.1 dADD1 and XNP do not directly interact but both interact with HP1a 
and HP1b 
Both dADD1 and XNP were previously identified to interact with HP1a [46, 
56]. Since both proteins share this common interaction partner, but do not rely on the 
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presence of the other protein for chromatin recruitment we decided to further 
investigate the nature of the relationship between these two proteins.  
Previous reports indicated that all dADD1 isoforms are capable of interacting 
with the long isoforms of XNP, although these interactions were based on the 
detection of a molecular weight band in in vitro binding assays that was much 
smaller than dADD1-PA [42]. We therefore co-transfected dADD1-PA Flag/HA 
tagged stable cells with a Myc tagged long isoform of XNP-PA/B and pulled down 
either dADD1 or XNP using Flag and Myc antibodies, respectively. Eluate samples 
from dADD1 pull downs showed no evidence of an interaction with XNP (Figure 15 
A, a-Flag IP Elu. Myc). Conversely, dADD1 was detected in the eluate samples from 
XNP pull downs, however, dADD1 is also present in the bead-binding control 
sample indicating that dADD1 binds independently to the beads (Figure 15 A, 
compare Bead Only and a-Myc IP Elu. HA). As a positive control, endogenous HP1a 
was detected in both dADD1 and XNP pull downs (Figure 15 A, a-Flag IP Elu. and 
a-Myc IP Elu. HP1a).  
To confirm these results we performed pull downs from cells overexpressing 
either dADD1-PA or XNP-PA/B and performed MS to determine if the long isoforms 
of either protein interacted with endogenous dADD1 or XNP. Again we did not 
detect any interaction between dADD1 or XNP, but see both proteins interacting 
with HP1a and HP1b (Figure 15 B). Unfortunately, we were unable to re-confirm the 
interaction between dADD1 and HP1b by targeted Co-IP analysis due to the 
inability of the HP1b antibody to detect an epitope on western blot and the lack of an 
HP1b cDNA clone for analysis of tagged constructs. Although we were not able to 
detect a direct interaction between dADD1 and XNP, the presence of common 
interaction partners indicates that although these proteins do not directly work 
together, they may act in common pathways and may share many interaction 
partners. 
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Figure 15: dADD1 and XNP do not directly interact but both interact with HP1a and HP1b. 
Western blot and Mass Spec data detect no interaction between dADD1 and XNP but both interact with 
HP1a and HP1b. A) Co-transfection of dADD1-Flag/HA tagged stable cell line with XNP-Myc tagged 
construct. Pull down of dADD1 (+a-Flag IP) contains no XNP-Myc in the eluate. Pull down of XNP (+a-
Myc IP) shows a band corresponding to dADD1-Flag/HA in the eluate, however, a band corresponding 
to dADD1-Flag/HA is also present in the bead only IP control. Both proteins pull down HP1a B) Flag 
pull downs of Flag tagged dADD1-PA (dADD1 IP) or XNP-PA/B (XNP IP) from S2 cells followed by 
MS. Pull down of dADD1 or XNP does not detect significant amounts of the corresponding proteins by 
MS. dADD1 IP and XNP IP are significantly enriched for HP1a and HP1b. Bars represent the Log2 iBAQ 
dADD1 IP or XNP IP/Control IP. Control IP of was a Flag IP on untransfected cell lysates. P-Values 
represent the enrichment of each peptide in a single IP sample compared to the control IP. MS pull 
downs and protein preparation performed by Dr. Andreas Thomae and MS peptide identification by 
Dr. Ignasi Forne.  
 
3.3.1 dADD1 and XNP interact genetically 
Habituation assays demonstrated that loss of either dADD1 or XNP results in 
learning and memory phenotypes giving merit to the idea that these proteins may 
interact in similar pathways. We thus investigated if these proteins genetically 
interact. To do so we generated mutants from isoginized stocks that contained 
combinations of dADD12 and XNP403 or XNP406 mutations.  
Homozygous XNP mutants display only one visible phenotype when 
compared to the Iso31 controls. Approximately 25% of homozygous XNP403 and 50% 
of XNP406 mutants develop melanotic tumors in the abdomen (Figure 16 A). 
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Melanotic tumors are non-cancerous lesions formed by the fly immune system 
encapsulating self-cells resulting in the formation of a black tumorous mass [57]. 
Although the exact cause of melanotic tumor formation is not known, it has been 
linked to deregulation of stress responses and apoptosis pathways [58]. 
Interestingly, addition of a single copy of the dADD12 allele into either homozygous 
XNP mutant background resulted in an increase in melanotic tumor incidence as 
well as an increase in size of the melanotic mass (Figure 16 B).  
dADD12 homozygous mutants display no visible phenotypes, and the 
addition of a single copy of either XNP403 or XNP406 mutant allele caused no changes 
in wing or eye shape, size or patterning, bristle patterning, thorax closure or 
melanotic tumor formation (data not shown). However, the addition of one mutant 
copy of XNP to homozygous dADD12 flies resulted in increased organismal lethality 
during pupal stages. All tested mutants show comparable rates of lethality at larval 
stages , indicating that a similar percentage of larvae successfully pupariate, but 
many of the double mutants do not eclose and die in the pupal casing.  
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Figure 16: Combination mutations of dADD1 and XNP show increased incidence of melanotic tumors 
as well as decreased pupal survival. 
Quantification of mutant phenotypes of dADD1 and XNP combination mutants. A) Addition of a single 
copy of dADD12 mutant allele increases melanotic tumor incidence in homozygous XNP adult flies. 
Both control Iso31 and dADD12 homozygous mutants do not form melanotic tumors. XNP homozygous 
mutants do form melanotic tumors, but the rate of melanotic tumors increases with the addition of a 
single copy of dADD12. B) Melanotic tumors in the abdomen of adult females. Iso31 and dADD1 flies 
show no melanotic tumors while XNP mutants show small melanotic masses in the abdomen. The size 
of these masses increases in the double mutants. Flies chosen were representative of the specified 
genotype. Each genotype contains images of two different adult females. C) Addition of a single copy of 
either XNP403 or XNP406 to homozygous dADD1 mutants results in increased pupal lethality. Rates of 
pupariation are similar between control Iso31 and mutant lines, but fewer adults eclose in the double 
mutant context.  
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While our data does not support the previous report of a direct protein-
protein interaction between dADD1 and XNP, the exacerbation of mutant 
phenotypes in genetic combination strongly suggests that these proteins do indeed 
work in common pathways. Although the mechanisms that result in increased 
melanotic tumor incidence or increased pupal lethality are difficult to elucidate, we 
interpret these results to indicate that dADD1 and XNP both function in pathways 
important for development and also resistance to stress.  
3.4 Other interaction partners of dADD1 and XNP 
3.4.1 dADD1 interacts with chromatin proteins Bonus, Eggless and 
Mod(mdg4) 
A previous study identified a number of interaction partners of dADD1, 
which included the chromatin proteins Eggless, Bonus and Mod(mdg4) [56]. Eggless, 
also known as SetDB1, is one of two Drosophila H3K9 methyltransferases that 
implements H3K9me3 marks onto histone tails. This protein is important for 
recruitment of HP1a to chromosome 4, as Eggless mutants show a loss of HP1a 
staining at chromosome 4 in salivary polytene chromosome squashes [59]. Bonus is 
another chromatin associated protein that has been implicated in both positive and 
negative regulation of chromatin [60]. In brains, Bonus associates with the 
transcription factor Fruitless, a protein important for male specific neuronal 
development. In males, Bonus recruits Histone deacetylase 1 to chromatin at 
Fruitless target genes causing formation of male typical neurons, while in females 
Bonus recruits HP1a to these same genes resulting in the development of female 
typical neurons [61]. Mod(mdg4) is an insulator protein that works together with the 
highly conserved insulator protein CTCF and regulates proper expression of the 
bithrorax complex in Drosophila [62].  
Pull downs of dADD1 from stable dADD1-PA-FLAG/HA expressing cells co-
transfected with Myc-tagged Eggless, Mod(mdg4) and Bonus re-confirmed the 
interaction between these proteins and dADD1 (Figure 17 A). The interaction 
between dADD1 and endogenous Mod(mdg4) and Bonus was furthermore detected 
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in MS analysis of dADD1 pull downs from S2 cells. However, this experiment did 
not detect any peptides corresponding to Eggless in dADD1 pull downs (Figure 17 
B). Lack of Eggless in the dADD1 pull downs could be the result of IP conditions, 
which in the MS experiment was performed by Dr. Andreas Thomae and involved a 
very different extraction protocol. MS analysis of pull down fractions interacting 
with XNP, which were also performed by Dr. Andreas Thomae, showed that XNP 
interacts with the dADD1 interaction partner Mod(mdg4) (Figure 15 B, Figure 17 B). 
Further analysis of the MS pull down data for dADD1 and XNP is discussed in 3.4.3 
Pull downs of dADD1 and XNP identify a number of new interaction partners. 
 
 
Figure 17: dADD1 interacts with chromatin proteins Eggless, Mod(mdg4) and Bonus. 
A) Pull downs of Flag/HA tagged dADD1-PA from S2 stable cells co-transfected with Myc tagged 
Eggless, Mod(mdg4) and Bonus. Eluate samples from dADD1 pull downs contain Eggless, Mod(mdg4) 
and Bonus proteins. B) Flag pull downs of Flag tagged dADD1-PA (dADD1 IP) or XNP-PA/B (XNP IP) 
from S2 cells followed by MS. Peptides for both Bonus and Mod(mdg4) were identified in the dADD1 
IP, while only Mod(mdg4) peptides were identified in the XNP IP. Peptides corresponding to Eggless 
were not identified in either IP. Bars represent the Log2 iBAQ dADD1 IP or XNP IP/Control IP. Control 
IP of was a Flag IP on untransfected cell lysates. P-Values represent the enrichment of each peptide in a 
single IP sample compared to the control IP. MS pull downs and protein preparation performed by Dr. 
Andreas Thomae and MS peptide identification by Dr. Ignasi Forne. 
 
3.4.2 Overexpression of Bonus in egg chamber follicle cells recruits dADD1 
and HP1b to euchromatically localized Bonus foci 
In addition to its interaction with heterochromatin associated proteins HP1a 
and Eggless, we wanted to further elucidate the significance of the interaction of 
dADD1 with Bonus. Bonus is the only Drosophila homologue of the mammalian TIF1 
family proteins that are important for many transcriptional and chromatin 
regulatory processes and are also known to phosphorylate HP1 proteins [60, 63, 64]. 
 
R e s u l t s  
53 
In nurse cells Bonus is normally uniformly distributed across euchromatin and 
shows a chromatin localization pattern similar to HP1b (Figure 11, e and f).  
Overexpression of Bonus in egg chamber somatic follicle cells using a TJGal4 
driver results in the formation of punctate, euchromatically localized Bonus foci. 
These foci overlap with DAPI stained DNA regions, indicating that these foci are not 
just protein aggregates, but may represent clustering of euchromatic domains 
enriched with Bonus. Interestingly, both dADD1 and HP1b are recruited to Bonus 
foci while XNP, HP1a, H3.3 and H3K9me3 show no enrichment (Figure 18, Figure 19 
and Figure 20). The specific recruitment of both dADD1 and HP1b to Bonus foci, 
gives merit to the idea that dADD1 can also be recruited into euchromatin and forms 
a euchromatin-specific complex with Bonus and HP1b.  
 
 
Figure 18: Overexpression of Bonus recruits dADD1 but not XNP to euchromatic Bonus foci. 
Control and Bonus-RFP (BonRFP) overexpressing ovaries were fixed and stained together with each 
antibody to ensure comparable staining conditions. Follicle cell expression of Bonus was driven using a 
TJGAL4 diver a-b) Staining of dADD1endoGFP control ovaries together with ovaries overexpressing 
BonRFP in ovary follicle cells stained with the dADD1 antibody. dADD1 and Bonus co-localize at 
euchromatin in BonRFP overexpressing follicle cells. d) Staining of shgRFP control ovaries and BonRFP 
overexpressing ovaries with the XNP antibody. XNP staining is unchanged in control and BonRFP 
follicle cells. 
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Figure 19: Overexpression of Bonus recruits HP1b but not HP1a to euchromatic Bonus foci. 
Control and Bonus-RFP (BonRFP) overexpressing ovaries were fixed and stained together with each 
antibody to ensure comparable staining conditions. Expression of Bonus in follicle cells was driven with 
a TJGAL4 driver. a-b) Staining of shgRFP control ovaries together with ovaries overexpressing BonRFP 
in the ovary follicle cells with an HP1a antibody. HP1a chromatin localization is unchanged in BonRFP 
follicle cells in comparison to shgRFP controls. c-d) Staining of shgRFP control ovaries and BonRFP 
overexpressing ovaries with an HP1b antibody. HP1b co-localizes with BonRFP at follicle cell 
euchromatin. 
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Figure 20: Neither H3K9me3 or H3.3 is enriched at euchromatic Bonus foci. 
Control and Bonus-RFP (BonRFP) overexpressing ovaries were fixed and stained together with each 
antibody to ensure comparable staining conditions. Bonus was expressed using the follicle specific cell 
driver TJGAL4. a-d) Staining of shgRFP control ovaries together with ovaries overexpressing BonRFP in 
the ovary follicle cells with either an H3K9me3 or H3.3 antibody. Neither H3K9me3 or H3.3 are 
enriched at euchromatic Bonus foci at follicle cell chromatin.  
 
3.4.3 Pull downs of dADD1 and XNP identify a number of new interaction 
partners 
To identify new interaction partners of dADD1 and XNP we performed an 
MS analysis on pull downs of tagged dADD1-PA or XNP-PA/B from S2 cells. An 
interactome of dADD1-PA was recently published by the lab of Dr. Mitzi Kuroda, 
but no interactome has been published for XNP [56]. While XNP has been described 
to interact with HP1a and H3.3, additional interaction partners have yet to be 
identified.  
As discussed above, we re-identified a number of previously identified 
interactors of dADD1 through this MS approach including HP1a, HP1b, Mod(mdg4) 
and Bonus, confirming the validity of our data (Figure 15 and Figure 17). To further 
analyze the data a cut off value of log2 3 fold iBAQ dADD1/S2 Control and a 
maximum P-Value of 0.06 was used to denote a significant protein interaction. While 
typically a P-Value of 0.01 or 0.05 are taken to denote significance we lowered our 
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cut off to 0.06 bases on the P-Value of Bonus, a known interactor of dADD1, which 
was 0.0505.  
From the dADD1 pull downs we identified a total of 54 proteins that 
interacted specifically with dADD1 and did not interact with XNP (Full list in 
Supplementary Materials Table 4). The top 10 interacting proteins of dADD1 are 
listed in Table 1. These proteins were enriched for proteins involved in cell cycle 
progression and mitotis such as Cyclin dependent kinase 5 (cdc5) and Chromator 
(Chro). Additionally, several chromatin and DNA binding proteins that specifically 
interacted with dADD1, are also known to interact with each other, suggesting 
dADD1 is involved in higher order protein complex formation. For example, the 
protein proliferation disrupter (Prod), which had the highest log2 fold enrichment of 
all dADD1 specific interactors, also interacts with the dADD1 specific interaction 
partner Chro. Prod also interacts with Germ line transcription factor 1 (Gnf1) and 
putzig (Pzg), proteins that were significant interactors of both dADD1 and XNP in 
our MS data sets. Interestingly, in addition to its role in mitosis and cell proliferation, 
prod is a telomeric associated protein that functions as a repressor of the telomeric 
transposon HeT-A, and both Chro and Pzg co-localize with prod at telomeres [65, 
66].  
 
Table 1: Top 10 dADD1 specific interactors 
List of the top 10 proteins that interact with only dADD1. FB ID numbers are the Flybase gene 
identification number give to all proteins listed on Flybase, an online Drosophila resource.  
 
 
Gene Name FB ID
Log2 
dADD1/Control
P-Value
prod FBgn0014269 12.02 1.53E-03
Hsp60 FBgn0015245 11.37 6.06E-11
Eb1 FBgn0027066 11.19 1.07E-07
Chro FBgn0044324 10.74 6.74E-04
Vps29 FBgn0031310 10.33 6.91E-10
CG15107 FBgn0041702 9.59 4.88E-04
RpL21 FBgn0032987 9.32 2.75E-11
Hsc70-5 FBgn0001220 8.80 5.51E-07
ncd FBgn0002924 8.52 5.40E-03
deltaCOP FBgn0028969 8.09 2.15E-03
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Using the same cut off parameters used to determine significant protein 
interactions for dADD1 we identified 99 proteins that interact specifically with XNP 
(Full list in Supplementary Materials Table 5). The top 10 interacting proteins of XNP 
are listed in Table 2. Similar to dADD1 these proteins were enriched for protein 
involved in mitosis and included a number of chromatin associated and DNA 
binding proteins. XNP associates with a number of protein involved in DNA repair 
processes including the nucleotide excision repair proteins PCNA and Rad23, as well 
as DNA double-strand break repair protein Irbp, that is also involved in telomere 
maintenance. Many proteins that specifically associate with XNP are also involved in 
both positive and negative transcriptional regulation, such as Mta1-like, Mbf1, Mlf, 
MEP-1, Mi-2 and Bin1. 
 
Table 2: Top 10 XNP specific interactors 
List of the top 10 proteins that interact with XNP only. FB ID numbers are the Flybase gene 
identification number give to all proteins listed on Flybase, an online Drosophila resource. 
 
 
Further analysis identified 100 shared protein interaction partners of both 
dADD1 and XNP that have a log2 greater than 3 and a P-Value less than 0.06 (Full 
list in Supplementary Materials Table 6). Shared interaction partners are heavily 
enriched for chromatin-associated proteins and have GO term enrichment for 
chromatin-related processes, such as chromatin organization, modification and 
remodeling as well as heterochromatin assembly and organization. Further analysis 
suggests that both data sets are enriched for heterochromatic components previously 
Gene Name FB ID
Log2 
XNP/Control
P-Value
clu FBgn0034087 14.70 8.95E-12
RpL11 FBgn0013325 12.29 2.63E-03
Su(var)2-10 FBgn0003612 11.95 4.97E-12
CG43736 FBgn0263993 11.91 7.06E-12
CG9253-RA FBgn0032919 11.39 1.10E-08
tsr FBgn0011726 10.86 3.49E-03
CHIP FBgn0027052 10.64 5.67E-08
NHP2 FBgn0029148 10.26 8.31E-09
CG8036 FBgn0037607 9.93 4.92E-04
Nop60B FBgn0259937 9.66 3.94E-03
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found to be enriched at telomeric sequences [67]. Table 3 includes a list of GO scores 
for shared protein interactors of dADD1 and XNP. 
 
Table 3: Gene ontology scores of shared dADD1 and XNP interactors 
 
 
In addition to interactors HP1a, HP1b and Mod(mdg4), some of the newly 
identified proteins shared between dADD1 and XNP are involved in regulation of 
chromatin include dre4, Chromatin assembly factor 1-p55 subunit (Caf1-55), 
Structure specific recognition protein (Ssrp) and Insulator binding factor 1 (Ibf1). We 
also see both dADD1 and XNP interacting with a number of heatshock proteins 
including Hsp83, the Drosophila homologue of Hsp90, which has been implicated in 
negative regulation of transcription by stabilization of paused polymerases [68].  
Both dADD1 and XNP also significantly interact with the H2A variant H2Av 
and H4. While H4 is a member of the canonical histone octomer, H2Av is a H2A 
variant that replaces H2A in nucleosomes. H2Av has been implicated in DNA 
damage response, where phosphorylation of H2Av tails is important in the 
recognition and repair of double-strand DNA breaks [69]. Peptides corresponding to 
H3.3 as well as H2B were also found within the MS data set, all with log2 values 
GO term P-Value Matches
Mitotic cell cycle 2.96E-14 34
Spindle organization 9.52E-12 22
Chromatin organization 1.26E-05 20
Chromosome organization 3.50E-05 23
Cellular response to stress 1.56E-04 22
Regulation of chromatin assembly or disassembly 3.42E-04 5
DNA conformation change 9.02E-04 11
Regulation of chromatin organization 2.90E-03 8
Cellular response to DNA damage stimulus 5.70E-03 14
DNA replication 2.14E-02 8
Chromatin modification 2.48E-02 12
Gene expression 3.15E-02 41
Heterochromatin assembly 3.32E-02 4
DNA packaging 3.47E-02 9
Heterochromatin organization 3.74E-02 5
Chromatin remodeling 3.44E-02 8
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greater than 3, however, all had P-Values greater than the 0.06 cutoff set to specify 
significant interactions. The identification of histones as well as histone variants in 
our MS data set could suggest that similar to ATRX, dADD1 and XNP may play a 
role in shuttling and replacement of histones. 
3.5 Effect of loss or overexpression of dADD1 and XNP on 
chromatin  
3.5.1 Loss of dADD1 or XNP does not affect localization of HP1a, HP1b or 
H3.3 to chromatin 
Since both dADD1 and XNP have been shown to interact with chromatin 
proteins HP1a and HP1b we decided to investigate the effect that loss of either 
dADD1 or XNP had on localization of HP1a and HP1b to chromatin. Complete loss 
of either protein did not affect the chromatin localization of HP1a to 
heterochromatin, nor did loss affect the localization of HP1b to euchromatin (Figure 
21). This demonstrates that neither dADD1 or XNP is necessary for chromatin 
recruitment of either HP1a or HP1b. Similar results were obtained for H3.3, where 
homozygous dADD12 and homozygous XNP403 mutants show similar H3.3 
chromatin deposition as control shgRFP flies (Figure 13).  
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Figure 21: Localization of HP1b and HP1a to chromatin is independent of the presence of dADD1 and 
XNP. 
Loss of dADD1 or XNP does not affect the localization of either HP1a or HP1b to nurse cell and follicle 
cell chromatin. shgRFP controls as well as mutants were fixed and stained together to maintain 
consistency as well as were mounted on the same slide and imaged using the same imaging settings. a-
b) dADD12 homozygous mutants show normal HP1a and HP1b localization patterns at chromatin in 
comparison to shgRFP control egg chambers. c-d) HP1a and HP1b are recruited normally to XNP403 
homozygous mutant chromatin in follicle cells and nurse cells.  
 
The results for H3.3 and HP1a were re-confirmed through western blot of 
ovary cell lysates of homozygous dADD12 and homozygous XNP403 mutant flies 
(Figure 22). Total protein levels of H3.3 and HP1a are unchanged in mutants 
compared to control Iso31 stock. Levels of HP1b could not be analysed as the HP1b 
antibody was unable to detect HP1b on western blot. We also tested both dADD1 
and XNP mutants for H3K9me3 levels and found that the homozygous dADD12 
mutants but not the XNP403 mutants show a slight decrease in the total cellular levels 
of H3K9me3. However, quantifications of H3K9me3 levels in ovary follicle cells did 
not detect any difference in H3K9me3 levels between dADD12 homozygous mutants 
and shgRFP control ovaries (data not shown). The decrease in H3K9me3 may be the 
result of a reduction in the recruitment of the dADD1 interaction partner Eggless, an 
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H3K9 methylatransferase, to chromatin due to the loss of dADD1. This suggests that 
dADD1 may be important in maintenance and regulation of cellular H3K9me3, 
potentially through the recruitment of Eggless. 
 
 
Figure 22: Western blot of whole cell ovary lysates reveals decreased H3K9me3 in homozygous dADD12 
mutant ovaries. 
Whole cell lysates of ovaries from control Iso31 ovaries as well as homozygous dADD12 and XNP403 
ovaries. Ovaries were dissected from females fattened on yeast paste for two days. Total protein levels 
were standardized before running on western blot. Tubulin was used as a loading control. Both HP1a 
and H3.3 levels remain unchanged in mutant ovaries compared to Iso31 control. H3K9me3 levels are 
decreased in the dADD12 homozygous mutants but not in the XNP403 homozygous mutants in 
comparison to control Iso31. The lower molecular weight band in the H3K9me3 sample corresponds to 
the predicted weight of histone 3.  
 
3.5.2 Overexpression of dADD1 increases cellular H3K9me3 and H3.3 levels 
Chromatin immunoprecipitation (ChIP) profiles of dADD1 showed a 
significant enrichment of dADD1 at heterochromatin sequences and dADD1 
associates with a number of heterochromatin components such as HP1a and 
H3K9me3 [56]. We thus tested the effect that overexpression of dADD1 has on total 
levels of heterochromatin-enriched components HP1a, H3.3 and H3K9me3 by 
western blot. Total cell lysates of dADD1-PA expressing stable cells revealed that 
overexpression of dADD1 increased total levels of cellular H3.3 and H3K9me3, but 
HP1a levels remained unchanged (Figure 23).  
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Figure 23: Overexpression of dADD1 in S2 cells increases cellular levels of H3K9me3 and H3.3. 
Whole cell lysates of either control or dADD1 stable cell lines overexpressing dADD1-Flag/HA. Protein 
concentrations were standardized before running on western blot and total protein levels are 
comparable based on similar tubulin intensities in both samples. H3.3 and H3K9me3 levels increased in 
dADD1 overexpressing cells while HP1a remains unchanged.   
 
Together with the data from homozygous dADD12 ovary cell lysates it 
appears that dADD1 plays a role in regulating cellular H3.3 and H3K9me3 levels. 
The function on H3K9me3 levels may be the result of the interaction of dADD1 with 
the H3K9 methyltransferase Eggless. Eggless is one of three H3K9 
methyltransferases in Drosophila, the others being Su(var)3-9 and G9a, however, only 
Eggless and Su(var)3-9 implement H3K9me3 marks at HP1a bound heterochromatin 
[59]. It is possible that the interaction of Eggless with dADD1 recruits Eggless to 
chromatin facilitating tri-methylation of H3K9.  
How overexpression of dADD1 leads to increased H3.3 is less clear, as 
dADD1 has not been shown to interact with either XNP or HIRA, the two Drosophila 
proteins responsible for replication independent deposition of H3.3 [53]. However, 
H3.3 did show up in our MS data set as an interactor of dADD1 and XNP, having 
significant log2 vales of of 9.5 and 8.5 respectively, but with P-values of 0.1 which 
was above our chosen P-Value cut off of 0.06. It is possible that H3.3 shows up in the 
MS data set due to the interaction of dADD1 and XNP with H3.3-rich 
heterochromatin, which is also pulled down with these proteins during immuno-
precipitation. Or it is possible that dADD1 binds directly to H3.3 through its ADD-
domain binding to tri-methylated lysine 9 on histone H3.3. In any case the 
relationship between dADD1 and H3.3 needs to be further investigated.  
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3.5.3 Overexpression of dADD1 but not XNP increases incorporation of 
HP1a, H3.3 and H3K9me3 into heterochromatin 
To better understand the role that dADD1 and XNP play at heterochromatin 
we overexpressed dADD1 and XNP in ovary follicle cells and performed a co-
localization analysis with identified interacting chromatin components. To perform 
these experiments, we first generated a fly line that expressed a C-terminal GFP 
tagged dADD1-PA construct under the control of a UAS promoter. Overexpression 
of XNP was achieved using a fly line containing an inducible XNP-HA construct, 
again under the control of a UAS promoter, that had been previously generated by 
the lab of Dr. Marc Muskavitch. 
Expression of both constructs was driven specifically in the egg chamber 
follicle cells using a TJGAL4 driver. Overexpression of dADD1-GFP resulted in 
significant enrichment of dADD1-GFP at heterochromatin, with a small amount of 
dADD1 localizing to euchromatic regions. In contrast, overexpression of XNP 
resulted in enrichment of XNP at euchromatin and general exclusion from 
heterochromatin. As discussed in 3.2.4 dADD1 and XNP are recruited independently to 
chromatin, overexpression of dADD1 or XNP did not result in increased recruitment 
of the other protein to chromatin suggesting these proteins are recruited 
independently (Figure 14).  
We then tested the ability of dADD1 to recruit or increase heterochromatin 
associated factors HP1a, H3.3 and H3K9me3 at heterochromatin or the ability of 
XNP to increase general incorporation of HP1a and H3.3. Similar to nurse cell 
chromatin in Figure 11, HP1a, H3.3 and H3K9me3 enriched at follicle cell 
heterochromatin in wild type ovaries (Figure 24 a, c and e and Figure 25 a and c). 
Overexpression of dADD1 increased enrichment of all of these heterochromatin 
proteins and histone methylation mark at heterochromatin (Figure 24 b, d and f). 
However, HP1a and H3.3 were not enriched in XNP-rich chromatin in XNP-
overexpressing cells, with both HP1a and H3.3 showing comparable stainings at 
XNP-HA follicle cell chromatin and shgRFP control chromatin (Figure 25). 
Enrichment of HP1a, H3.3 and H3K9me3 at heterochromatin in dADD1-
overexpressing cells is specific to these factors since we did not observe XNP 
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enrichment at heterochromatin in dADD1 overexpressing cells. Furthermore, this 
enrichment is not an artifact of overexpression as we observe no change in these 
chromatin factors in XNP overexpressing follicle cells.  
 
 
Figure 24: Overexpression of dADD1 in somatic ovary follicle cells increases incorporation of HP1a, 
H3.3 and H3K9me3 to heterochromatin. 
dADD1-GFP was overexpressed specifically in the egg chamber follicle cells using a TJGAL4 driver. 
Overexpression of dADD1-GFP results in accumulation of dADD1-GFP primarily at heterochromatin. 
shgRFP ovaries were used as a control and were stained, fixed and imaged together with the dADD1-
GFP ovaries to maintain consistency. a) HP1a localizes to follicle cell heterochromatin in shgRFP control 
ovaries. b) Overexpression of dADD1-GFP results in increased HP1a at heterochromatin in comparison 
to ovaries in a. c) H3.3 localizes to heterochromatin in ovary follicle cells in shgRFP control ovaries. d) 
H3.3 levels are increased at heterochromatin in ovary follicle cells overexpressing dADD1-GFP in 
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comparison to H3.3 in control shgRFP follicle cells in c. e) H3K9me3 shows enrichment at follicle cell 
heterochromatin in shgRFP control ovaries. f) Overexpression of dADD1-GFP in egg chamber follicle 
cells results in an increased deposition of H3K9me3 at dADD1-GFP rich heterochromatin in follicle cells 
in comparison to e.  
 
 
Figure 25: HP1a and H3.3 are not recruited to XNP rich chromatin in overexpressing cells. 
Overexpression of XNP-HA was specifically driven in egg chamber follicle cells using the TJGAL4 
driver. For consistency and comparability of images shgRFP control ovaries were fixed, stained and 
imaged together with XNP-HA overexpressing ovaries. a) HP1a is enriched at heterochromatin in 
control shgRFP follicle cells. b) Overexpression of XNP-HA in ovary follicle cells does not change the 
localization pattern, or increase chromatin associated HP1a. c) In control shgRFP egg chamber follicle 
cells H3.3 is enriched at heterochromatin. d) Overexpression of XNP-HA in egg chamber follicle cells 
does not alter the localization of H3.3 to chromatin. 
 
The data on dADD1 overexpression together with the nurse cell chromatin 
localization of HP1a, H3.3 and H3K9me3 in dADD12 homozygous mutant tissue 
suggests that dADD1 is sufficient, but not necessary to induce heterochromatin 
formation through recruitment of heterochromatin factors in vivo. 
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3.5.4 Overexpression of dADD1 in follicle cells recruits euchromatic 
proteins Bonus and HP1b into heterochromatin 
Further experiments were also undertaken to determine what effect 
overexpression of dADD1 has on its euchromatic interaction partners HP1b and 
Bonus. In follicle cells both HP1b and Bonus show euchromatic localization and are 
excluded from heterochromatin (Figure 26 a and c). Overexpression of dADD1-GFP 
in egg chamber follicle cells results in recruitment of both of these proteins to 
heterochromatin (Figure 26 b and d). Interestingly, it appears that dADD1 and 
Bonus are able to recruit one another to chromatin, as overexpression of either 
protein results in recruitment of the other to chromatin domains enriched for either 
dADD1 or Bonus (Figure 18 b and Figure 26 b). These dADD1 or Bonus-enriched 
chromatin domains also contain increased levels of HP1b, indicating that either 
dADD1 or Bonus or both are capable of recruiting HP1b to chromatin. However, it 
was shown in Figure 13 that dADD1 is not necessary for the recruitment of HP1b to 
chromatin, leaving the possibility that Bonus is the protein important for HP1b 
recruitment to chromatin.  
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Figure 26: Overexpression of dADD1 recruits euchromatic proteins Bonus and HP1b to 
heterochromatin. 
Overexpression of dADD1-GFP in egg chamber follicle cells using a TJGAL4 driver. Control shgRFP 
ovaries were fixed, stained and imaged together with the dADD1-GFP overexpressing ovaries. a) Bonus 
localizes to euchromatin and is excluded from heterochromatin in egg chamber follicle cells in control 
shgRFP ovaries. b) Overexpression of dADD1-GFP recruits Bonus to heterochromatin. c) HP1b localizes 
to follicle cell euchromatin and is excluded from heterochromatin in shgRFP control egg chambers. d) 
Overexpression of dADD1-GFP increases HP1b at follicle cell heterochromatin. 
 
As HP1b was also identified as an interaction partner of XNP we tested next 
if XNP was capable of recruiting HP1b to chromatin. We again overexpressed XNP-
HA in egg chamber follicle cells and stained for HP1b. However, overexpression of 
XNP did not increase the recruitment of HP1b to XNP-HA rich regions at 
euchromatin (Figure 27).  
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Figure 27: Overexpression of XNP does not increase recruitment of HP1b to XNP rich chromatin. 
To ensure consistency and comparability of results control shgRFP and XNP-HA overexpressing 
ovaries were fixed, stained and imaged together. a) HP1b localizes to euchromatin and is excluded 
from heterochromatin in control shgRFP follicle cells. b) Overexpression of XNP-HA does not change 
the recruitment of HP1b to chromatin.  
 
3.5.5 Loss of dADD1 and XNP results in impaired resolution of double-
strand DNA breaks 
Based on the MS pull down data, both dADD1 and XNP were shown to 
significantly interact with the Histone variant H2Av. H2Av is a histone variant that 
replaces H2A in nucleosomes and is typically enriched in heterochromatin [70]. 
However, H2Av is also incorporated into euchromatic gene coding sequences and 
transposons [71]. H2Av is also important in response to DNA double-strand breaks, 
where serine 137 on the H2Av tails near the double-strand break are phosphorylated 
[69]. In Drosophila, phosphorylated H2Av is referred to as g-H2Av and is used as a 
marker for double-strand DNA breaks [72]. We furthermore observed that both 
dADD1 and XNP significantly interacted with the DNA repair Tip60 complex 
member Pontin, while another complex member Reptin was a significant interactor 
of dADD1 also identified in the XNP interactor MS data set (log2 4.2 and P-Value 
0.07). Importantly, the Tip60 complex is important for acetylation of g-H2Av and for 
the replacement of g-H2Av with un-phosphorylated H2Av in response to DNA 
damage [73].  
Analysis of the proteins that interacted with both dADD1 and XNP showed 
that the shared interactors were enriched for pathways involved in DNA repair. 
Based on the interaction of dADD1 and XNP with H2Av, as well as with the DNA 
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repair associated proteins Pontin and Reptin, we tested the ability of dADD12 and 
XNP403 homozygous mutants to efficiently repair double-strand DNA breaks. To do 
so we compared levels of g-H2Av in nurse cell chromatin in shgRFP control ovaries 
and homozygous dADD12 and XNP403 mutants from female flies that were placed on 
food containing 0.25 µg/ml hydroxyurea for 4 days. Hydroxyurea induces DNA 
double-strand breaks by stalling DNA replication machinery through depletion of 
the dNTP pool, which results in the replication machinery dissociating from 
replicating DNA [74].  
Untreated XNP403 mutants show no change in g-H2Av levels in nurse cell 
chromatin when compared to shgRFP controls in stage matched egg chambers 
(Figure 28 a and b). Homozygous dADD12 mutants show a slight increase in g-H2Av 
at nurse cell chromatin in comparison to stage matched egg chambers of shgRFP 
control flies, indicating that these mutants have an impaired DNA damage response 
(Figure 28 c and d). However, both homozygous XNP403 and dADD12 mutants 
treated with hydroxyurea show an increased amount of g-H2Av in nurse cell 
chromatin when compared to shgRFP control stage matched egg chambers (Figure 
29). While the dADD12 mutants already show an impaired DNA damage response 
under normal conditions, the addition of replication stress visibly increases that 
amount of g-H2Av at nurse cell chromatin in comparison to the shgRFP controls.  
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Figure 28: Homozygous XNP403 and dADD12 mutants show similar g-H2Av stainings under normal 
growth conditions. 
Maximum Z-projections of ovaries from XNP403 and dADD12 mutants compared to shgRFP control 
ovaries. Mutant and control ovaries were fixed and stained in the same vials and were mounted and 
imaged on the same slides using identical imaging settings. Comparisons are only possible between 
mutant and control ovaries from the same slide. The germarium shows a higher level of g-H2Av 
staining in both control and mutant ovaries compared to later stage egg chambers. a-b) Comparison of 
XNP403 mutant ovaries to shgRFP control ovaries shows no difference in g-H2Av in stage matched egg 
chambers at nurse cell chromatin. c-d) dADD12 homozygous mutants show a slightly elevated level of 
g-H2Av at nurse cell chromatin in comparison to control shgRFP stage matched egg chambers. Arrows 
denote comparable nurse cell chromatin.  
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Figure 29: Hydroxyurea treatment of adult females leads to increased g-H2Av accumulation in XNP403 
and dADD12 mutant ovaries. 
Maximum Z-projections of ovaries from XNP403 and dADD12 mutants compared to shgRFP control 
ovaries. Mutant and control ovaries were fixed and stained in the same vials and were mounted and 
imaged on the same slides using identical imaging settings. Comparisons are only possible between 
mutant and control ovaries from the same slide. a-b) XNP403 mutant ovaries show increased g-H2Av in 
comparison to shgRFP control stage matched ovaries in adult female flies treated for 4 days with 
hydroxyurea. c-d) dADD12 mutant ovaries display an increase in g-H2Av in nurse cell chromatin in 
comparison to shgRFP control stage matched egg chambers. Arrows denote comparable nurse cell 
chromatin.  
 
These results indicate that dADD1 and XNP mutant cells accumulate g-H2Av 
at chromatin containing DNA double-strand breaks, indicating that these proteins 
are important for DNA repair. This function could be mediated through association 
of dADD1 and XNP with Tip60 complex members Pontin, Reptin and H2Av. 
However, further work needs to be done to better understand the mechanism of 
how dADD1 and XNP function in DNA repair. 
3.5.6 dADD1 and XNP regulate transposon sequences 
Analysis of dADD1 ChIP data from the lab of Dr. Mitzi Kuroda revealed a 
number of dADD1 enriched genomic domains correlating with known transposon 
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sequences. As ATRX had been previously shown to be important for transposon 
silencing in mammals, we decided to further investigate if dADD1 and XNP also 
regulate transposon silencing. To this end we compared transcript levels of a 
number of transposons in ovaries from Iso31 control flies to both dADD12 and XNP403 
homozygous mutants by Real Time (RT)-qPCR.  
We specifically tested the expression of four non-LTR transposons (297, roo, 
mdg3 and 412) and one telomeric transposon (HeT-A) on two independent RNA 
extractions from female ovaries. Transcription of these transposons was 
standardized to four different housekeeping genes, actin, tubulin, Rpl13 and Rpl32. 
All tested transposons were regulated by either dADD1 or XNP and in some cases 
by both (Figure 30). 297 and HeT-A showed significant increases in transcript levels 
in XNP homozygous mutants with a 5.8 and 2.6-fold upregulation, respectively, in 
comparison to Iso31 controls. Homozygous dADD1 mutants showed a significant 
upregulation of 412, with a 6.5-fold increase in transcript levels in comparison to 
Iso31 controls. Transcript levels of roo and mdg3 increased in both dADD1 and XNP 
homozygous mutants by between 4.8 -11.2 fold, in comparison to Iso31 controls.   
 
 
Figure 30: Loss of dADD1 or XNP results in increased transcription of transposons. 
RT-qPCR measuring transposon transcription in dADD12 or XNP403 homozygous mutants standardized 
to Iso31 control transcript levels. Two independent RNA extracts, each containing ovaries from 10 
females, were compared to four housekeeping genes. Both dADD1 and XNP regulate transposons with 
dADD1 regulating roo, mdg3 and 412 and XNP regulating 297, roo, mdg3 and HeT-A. RT-qPCR 
performed by Ian Will and Isabell Grass. P-Value calculations performed by Marco La Fortezza. 
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Combined, these data indicate that dADD1 and XNP have many functions at 
chromatin and have a multitude of interaction partners mediating these diverse 
functions. While dADD1 and XNP may not be essential for the deposition of HP1a, 
HP1b or H3.3 into chromatin, these proteins may play important roles in the 
replacement of g-H2Av into H2Av during DNA damage responses. The involvement 
of these proteins in regulation of transposons suggests that these two proteins are 
important for maintenance of genomic integrity.  
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4 Discussion 
4.1 dADD1 and XNP do not directly interact but function in 
similar pathways  
4.1.1 dADD1 and XNP do not physically interact  
Co-immunoprecipitation experiments in a previous study observed an 
interaction between dADD1 and XNP, and experiments with truncated proteins in in 
vitro assays suggested that all isoforms of dADD1 interact with the long isoform of 
XNP [42]. While an interaction between these two proteins may be expected based 
on sequence conservation with the single mammalian protein ATRX, our 
experiments could not re-confirm this proposed physical interaction between them.  
Specifically, co-expression of the long isoforms of dADD1 and XNP in S2 
cells followed by co-immunoprecipitation did not show any interaction between the 
two proteins. Eluate samples of pull downs of dADD1 did not contain any XNP 
constructs. While pull downs of XNP showed a slight enrichment for dADD1, this is 
likely an artifact of dADD1 binding independently to the Protein G sepharose beads 
as dADD1 was also present in the eluate of the bead binding control. We were also 
unable to identify an interaction between dADD1 and XNP through MS. The long 
isoforms of dADD1 and XNP were expressed and pulled down independently from 
S2 cells and associated proteins for both dADD1 and XNP were identified. In the 
dADD1 IP no endogenous XNP peptides were detected, and while a few peptides 
corresponding to dADD1 were present in the XNP samples, they were far below the 
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log2 and P-Values that denoted a significant interaction. As a positive control in both 
the dADD1 and XNP IPs we identified HP1a, a protein known to interact with both 
proteins.  
One of the reasons for the discrepancy between our work and the previous 
study is likely to be due to the difference in the observed molecular weight of the 
long isoform of dADD1 [42]. In the previous paper, identification of dADD1 was 
based on an anti-dADD1 antibody recognizing a band at the predicted weight of 130 
kD of the long isoform, however, we showed here that the long isoform of dADD1 is 
actually around 250 kD, which is much larger than expected. 
4.1.2 dADD1 and XNP show unique localization patterns at chromatin 
Chromatin localization of dADD1 and XNP was determined by analyzing 
immunohistochemical stainings of endogenous proteins in egg chamber nurse cells. 
Nurse cell chromatin is a fantastic system for investigating chromatin protein 
localization as the genome is endoreplicated, resulting in polytenized chromatin that 
enables simple visualization of chromatin domains. While many studies employ the 
use of larval salivary gland polytene chromosome squashes to visualize chromatin 
protein localization, endogenous antibodies were unable to identify dADD1 and 
XNP proteins at chromatin in salivary gland chromosome squashes (data not 
shown), likely because they are only expressed at low levels [47].  
However, we were able to detect dADD1 or XNP at nurse cell chromatin 
using an antibody raised against a peptide common to all isoforms of dADD1 by Dr. 
Andreas Thomae, and an antibody developed against a peptide common to all 
isoforms of XNP by the lab of Dr. Kami Ahmad [46]. Stainings of homozygous 
dADD12, XNP403 and XNP406 mutant ovaries confirmed that both antibodies are 
highly specific as no signal was detected at nurse cell chromatin in these mutants.  
We found that dADD1 and XNP showed unique chromatin localization 
patterns at nurse cell chromatin. In accordance with dADD1 ChIP data from the lab 
of Dr. Mitzi Kuroda, we observed enrichment of dADD1 at heterochromatin, where 
dADD1 significantly co-localized with the heterochromatin-associated protein HP1a 
[56]. However, a population of dADD1 was also present at euchromatin. In contrast, 
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XNP showed uniform localization to both heterochromatin and euchromatin, but 
surprisingly showed no enrichment at HP1a-rich chromatin. While these proteins do 
not show overlapping enrichment, they are both present at euchromatin and 
heterochromatin in nurse cells, where they may bind and regulate common 
chromatin elements.  
4.1.3 Chromatin recruitment of dADD1 and XNP is independent of one 
another 
ATRX is recruited to chromatin through a combination of the ADD domain 
binding to H3K9me3 marks on histones as well as through the HP1a-interacting 
domain binding to HP1a [26]. We observed that dADD1 is enriched at chromatin 
regions with high levels of H3K9me3 both in nurse cell chromatin and in HELA 
Kyoto cells suggesting that dADD1 is recruited to heterochromatin, at least in part, 
through binding of the ADD domain to H3K9me3. dADD1 also contains several 
putative HP1a binding sites so it is also possible that the interaction between dADD1 
and HP1a contributes to the localization of dADD1 to heterochromatin. 
Identification of the exact HP1a-interacting domain would allow for experiments to 
be performed that could determine if the interaction between HP1a and dADD1 
contributes to the localization of dADD1 to heterochromatin. While a mechanism by 
which dADD1 is recruited to heterochromatin is suggested by the presence of the 
ADD-domain, how XNP is recruited to chromatin is still unknown. However, the 
interaction of XNP with HP1a could offer one explanation of how XNP is recruited 
to chromatin, but more work needs to be done to identify the HP1a interacting 
domain within XNP.  
While the exact mechanism of chromatin recruitment of these proteins is still 
open for investigation, we have eliminated the possibility that either dADD1 recruits 
XNP or that XNP recruits dADD1 to chromatin. Since the SNF2-domain of ATRX is 
partially dependent on the ADD-domain for chromatin recruitment, we 
hypothesized that XNP could be recruited to chromatin through interaction with 
dADD1 or through dADD1-associated proteins. Co-expression experiments of 
dADD1 and XNP in HELA Kyoto cells to determine if dADD1 could recruit XNP to 
H3K9me3-rich chromatin regions were unsuccessful. However, we were able to 
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show that XNP localizes normally to nurse cell chromatin in dADD12 homozygous 
mutant ovaries. Furthermore, XNP was not recruited to dADD1-GFP rich 
heterochromatin in follicle cells overexpressing dADD1. XNP was the only 
chromatin factor from six chromatin factors tested that was not enriched at 
heterochromatin in dADD1-overexpressing cells.  
dADD1 is enriched at heterochromatin but also shows localization to 
euchromatic regions at nurse cell chromatin. The heterochromatic localization of 
dADD1 is likely dependent on the interaction of the ADD-domain with H3K9me3, 
but how dADD1 is recruited to euchromatin was unclear. Since XNP shows a 
uniform staining across nurse cell chromatin we also tested the possibility that XNP 
is important for dADD1 recruitment to euchromatin. dADD1 localizes normally to 
chromatin in XNP403 homozygous null mutants indicating the XNP is not necessary 
for recruitment of dADD1 to chromatin. Additionally, overexpression of XNP-HA in 
egg chamber follicle cells did not increase recruitment of dADD1 to XNP-HA rich 
chromatin regions, demonstrating that XNP does not recruit dADD1 to chromatin.  
Importantly, however, further testing of known dADD1 interaction partners 
revealed that Bonus recruits dADD1 to euchromatic Bonus foci in follicle cells 
overexpressing a Bonus-RFP construct. While Bonus is sufficient to recruit dADD1 to 
euchromatin, experiments to test the necessity of Bonus for euchromatic dADD1 
recruitment were not possible as homozygous bonus mutant flies are lethal. In 
addition, multiple attempts to generate mosaic bonus homozygous mutant tissue 
using the FLP/FRT system, a technique similar to the mammalian CRE/Lox system, 
in both follicle cells and nurse cells were unsuccessful. Experiments to express a 
RNAi targeting bonus could also be performed to circumvent this limitation. 
However, significant time would need to be invested to generate a new bonus RNAi 
line that is capable of driving expression in germline nurse cells, as current lines 
contain UASt promoters that only function in somatic tissue, such as follicle cells, 
where dADD1 is expressed at levels below the detection limit of our dADD1 
antibody. 
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4.1.4 Mutations in dADD1 and XNP give rise to similar mutant phenotypes 
Our biochemical interaction data, as well as chromatin localization data in 
homozygous dADD1 and XNP mutants and overexpressing follicle cells suggest that 
dADD1 and XNP do not interact. However, our detailed phenotypic analysis of the 
mutants revealed that they share common phenotypes. For example, both dADD1 
and XNP mutants show learning and memory defects, where mutant flies continued 
to startle in response to a light off stimulus.  
While these learning and memory defects were present in mutants that had a 
systemic decrease in dADD1 and XNP levels, further experiments investigating the 
effect of neuron specific loss of either protein should be performed. Preliminary 
results from RNAi knockdowns of either XNP or dADD1 using a neuron specific 
elavGAL4 driver showed that knockdown of XNP but not dADD1 in neurons caused 
learning and memory defects (data not shown). Since RNAi knockdown is rarely 
100% efficient, this data supports our mutant data where partial loss of XNP is 
sufficient to induce learning and memory deficits but a complete loss of dADD1 is 
needed for the same effect. While this data is promising, prelimainary assays to 
evaluate the efficiency of the RNAi knockdown in brains were not successful and 
therefore more work needs to be done to validate these results.  
Both homozygous dADD1 and XNP mutant flies also showed impaired DNA 
damage responses as measured by the accumulation of g-H2Av into nurse cell 
chromatin. In response to double-strand DNA breaks H2Av histones close to the 
DNA lesions are phosphorylated. In Drosophila these phosphorylated H2Av histones 
are called g-H2Av. dADD1 or XNP mutant flies treated with double-strand break 
inducing hydroxyurea both showed increased g-H2Av levels when compared to 
shgRFP wild type control tissues. Interestingly, Pontin, Reptin and H2Av, members 
of the Tip60 double-strand DNA repair complex, were identified in both dADD1 and 
XNP MS pulldowns. The Tip60 complex aids in the repair of double-strand DNA 
breaks by acetylating g-H2Av and facilitating the replacement of g-H2Av with un-
phosphoryated H2Av [73]. Accumulation of g-H2Av in homozygous dADD1 or XNP 
mutant tissue may be a result of an impaired DNA damage response, where DNA 
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lesions are not actually repaired, or because g-H2Av is not replaced with un-
phosphorylated H2Av.  
Further experiment are needed to determine if the accumulation of g-H2Av is 
the result of impaired DNA damage responses, inefficient turnover of g-H2Av or 
both. One way to test these possibilities would be to perform Terminal 
deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assays on ovaries 
from hydroxyurea-treated females. TUNEL assays label blunt ends of DNA double-
strand DNA breaks and increased TUNEL in homozygous mutants would indicate 
defective double-strand DNA break repair. However, if the TUNEL staining is 
similar to that of a wild type control tissue then the accumulation of g-H2Av is likely 
the result of defective g-H2Av/H2Av turnover in dADD1 or XNP mutant tissue.  
4.1.5 dADD1 and XNP interact genetically 
While we could not identify a direct interaction between dADD1 and XNP, 
the presence of shared interaction partners such as HP1a as well as the presence of 
similar phenotypes in the mutants suggested that these proteins may function 
together in similar biological pathways. To test this, we generated combination 
mutations of dADD1 and XNP null mutants and analyzed whether melanotic and 
lethality phenotypes were enhanced. Since homozygous double mutants were lethal, 
we scored individuals that were homozygous mutant for one gene and heterozygous 
mutant for the other.  
Originally, we observed that between 25-50% of homozygous XNP mutant 
flies developed small melanotic tumors in the abdomen. These melanotic masses are 
the result of the immune system attacking self-cells and may indicate increased 
stress within an organism [57, 58]. The addition of a single mutant copy of dADD1 to 
homozygous XNP mutant genotypes increased both the incidence as well as the 
severity of melanotic tumors. In these double mutants, melanotic tumor incidence 
increased to over 30% in the XNP403 mutant background and to over 85% in the 
XNP406 mutant background. Additionally, the tumors found within these double 
mutants were much larger than those in the homozygous XNP mutant flies alone.  
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We also quantified the effect that addition of a single mutant copy of XNP to 
dADD1 homozygous mutant flies had on fitness. While both the dADD1 
homozygous mutant flies as well as the dADD1 homozygous mutant flies containing 
one mutant copy of XNP showed no visual phenotypes, addition of one mutant copy 
of XNP caused an increase in pupal lethality. While homozygous dADD1 mutant 
larvae and double mutant larvae puparitate at similar rates, fewer double mutant 
adult flies eclosed with many dying in their pupal casing. This exacerbation of 
mutant phenotypes by addition of one muatant copy of either dADD1 or XNP lends 
support to the hypothesis that these two proteins function in related pathways. 
To further investigate these shared functions, experiments could be 
performed to analyze g-H2Av accumulation in double mutant ovaries of 
hydroxyurea-treated females. Increased levels of g-H2Av in double mutants in 
comparison to homozygous single mutants would demonstrate that these two 
proteins cooperate in DNA double-strand break repair responses. Cooperativity 
could also be demonstrated by enhancement of transposon silencing defects in 
double mutants. Unfortunately, experiments to test if learning and memory defects 
are exacerbated in dADD1 and XNP double mutant flies are not possible as double 
mutant flies showed a significant decrease in fitness that resulted in false negative 
scores in habituation assays (data not shown).  
4.2 Role of dADD1 and XNP at chromatin 
4.2.1 Involvement in stress responsive chromatin regulation 
Shared interaction partners of dADD1 and XNP that we identified through MS 
were enriched for proteins involved in both cellular response to stress and cellular 
response to DNA damage. Interestingly, in the unbiased analysis of the phospho-
proteome screen we performed to look at dynamic regulation of chromatin in 
response to stress signaling, we identified stress responsive phosphorylation sites in 
both dADD1 and XNP (data not shown). In response to reactive oxygen species 
stress, dADD1 becomes phosphorylated, while XNP is de-phosphorylated. 
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Interestingly, we also observed that interaction partners HP1a, HP1b and 
Mod(mdg4) become de-phosphorylated in response to ROS stress. The influence that 
these phosphorylation sites have on the chromatin regulatory function of these 
proteins is still unknown. However, in the case of dADD1 and XNP, stress 
responsive alterations in phosphorylation status may play a role in regulating DNA 
damage responses.  
4.2.2 dADD1 and XNP associate with a number of known telomere 
associated proteins 
Analysis of dADD1 or XNP interaction partners showed a significant 
enrichment of proteins with chromatin-related functions. In addition, this analysis 
identified 100 proteins that significantly interacted with both dADD1 and XNP. 
These included the previously identified shared interaction partner HP1a as well as 
HP1b and Mod(mdg4), proteins known to interact with dADD1. Our list of shared 
interaction partners was also enriched for proteins identified in an MS analysis for 
telomere-associated proteins, which identified both XNP and dADD1 as proteins 
that bind telomere-associated sequences [67].  
ATRX is a protein known to be important for maintenance of telomeres, as 
many tumors harboring ATRX mutations show alternative lengthening of telomeres 
[75]. We observed that XNP, but not dADD1, regulates transcription of telomere 
associated transposon HeT-A. While dADD1 homozygous mutant tissues showed 
no significant change in HeT-A transcription, experiments looking at telomere length 
indicated that loss of dADD1 but not XNP, slightly increased telomere length (data 
not shown). Telomere length was measured by RT-qPCR of HeT-A gDNA sequences 
in homozygous dADD1 and XNP mutant flies, that had been maintained in a 
homozygous state for over 10 generations. Genomic copy number of HeT-A served 
as an indicator of telomere length, where increased HeT-A indicated an increase in 
telomere length. While we observed a 1.4-fold increase in genomic HeT-A sequences 
in dADD1 mutants in comparison to a Iso31 wild type background, this fold increase 
was deemed to be statistically insignificant.  
dADD1 also significantly interacted with the protein Prod in our MS data set. 
Prod regulates telomeric HeT-A transcription and has been shown to interact with 
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Chro and Pzg at telomeres [66, 76]. Chro was enriched within the dADD1 
interactome while Pzg was found in both the dADD1 and XNP data sets. While these 
interactions are detected by MS, co-immunoprecipitation as well as co-localization 
experiments need to be performed to verify these interactions. Elucidation of the 
telomere-associated complexes that dADD1 and XNP are members of would enable 
a better understanding of the function of these two proteins at telomeres.  
4.2.3 Loss of dADD1 or XNP does not affect localization of HP1a, HP1b or 
H3.3 to chromatin 
MS identified that both dADD1 and XNP interact with chromatin proteins 
HP1a and HP1b. HP1a and HP1b have distinct functions at chromatin where HP1a 
binds H3K9me3 marked histones and aids in the formation of densely packed, 
silenced heterochromatin, while HP1b is important for activation of target genes 
within euchromatin [6, 54]. Since HP1a is a component of heterochromatin, regions 
enriched for HP1a in nurse cells and follicle cells were considered heterochromatic 
regions in our image analyses. At nurse cell chromatin HP1b showed a relatively 
uniform staining, although in some instances HP1b was excluded from HP1a rich 
heterochromatic regions. In follicle cells HP1b localized to euchromatin and 
appeared to be excluded from heterochromatin. 
In homozygous dADD12 and XNP403 mutant ovaries, HP1a and HP1b 
localized normally to nurse cell chromatin, demonstrating that neither dADD1 nor 
XNP is necessary for the recruitment of these proteins to chromatin. It is, however, 
possible that HP1a and HP1b recruit dADD1 and XNP to chromatin. Unfortunately, 
homozygous HP1a and HP1b mutants are lethal and only a few genetic tools exist to 
dissect HP1a and HP1b function. We were thus unable to perform reciprocal 
experiments to determine if HP1a or HP1b are necessary for chromatin recruitment 
of dADD1 and XNP.  
Peptides corresponding to H3.3 were also identified in both the dADD1 and 
XNP MS samples, suggesting that dADD1 and XNP may interact with H3.3. To this 
end we tested the effect that loss of dADD1 and XNP had on the incorporation of 
H3.3 into chromatin. In control wild type egg chambers, H3.3 stainings showed a 
very similar pattern to that of dADD1 where H3.3 is enriched at heterochromain but 
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is also present at euchromatin. The localization patterns of H3.3 was unchanged in 
homozygous dADD12 and XNP403 mutants, indicating that these proteins are not 
necessary for the incorporation of H3.3 into histones. This result is not surprising as 
previous work on XNP has shown HIRA, a second protein in Drosophila capable of 
replication independent H3.3 deposition, is able to compensate for loss of XNP [53]. 
4.2.4 dADD1 increases levels of HP1a, H3.3, H3K9me3, HP1b and Bonus at 
heterochromatin 
While dADD1 was not necessary for the recruitment of HP1a, HP1b or H3.3 
to chromatin, it was sufficient to recruit these factors to chromatin. Overexpression 
of dADD1 in egg chamber follicle cells resulted in increased dADD1 localization at 
heterochromatin and also increased heterochromatic localization of HP1a, HP1b and 
H3.3. Normally HP1b is excluded from follicle cells heterochromatin but 
overexpression of dADD1 resulted in HP1b localization to heterochromatin. The 
recruitment of HP1a, H3.3 and HP1b by dADD1 is specific to these factors since XNP 
was not recruited to dADD1 rich heterochromatin and overexpression of XNP did 
not result in increased recruitment of these proteins to XNP enriched domains. 
We also tested H3K9me3 levels in cells overexpressing dADD1 as the ADD-
domain of dADD1 binds to H3K9me3 and dADD1 interacts with the H3K9 
methyltransferase Eggless. In cells overexpressing dADD1, H3K9me3 levels were 
increased at heterochromatin. This increase is potentially due to dADD1 recruiting 
Eggless to chromatin where it can then tri-methylate H3K9. Interestingly, dADD1 
homozygous mutant ovaries showed a slight decrease in cellular H3K9me3 levels in 
cell lysates. Decreased H3K9me3 in dADD1 mutants further supports the notion that 
dADD1 is important for the implementation of H3K9me3 marks at chromatin. If the 
interaction with Eggless is required for the implementation of H3K9me3 at 
heterochromatin still needs to be tested.  
Taken together this data presents the possibility for a self-sustaining loop 
where dADD1 is recruited to heterochromatin through ADD-domain binding to 
H3K9me3 and recruiting Eggless. In turn Eggless then tri-methylates H3K9me3, 
facilitating further binding of dADD1. This may be one mechanism that maintains 
dADD1-rich domains at heterochromatin. Unfortunately, we were unable to test if 
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Eggless is recruited to heterochromatin in dADD1 overexpressing cells as Eggless 
antibodies generated by the lab of Dr. Elizabeth Kremmer did not detect Eggless at 
follicle cell or nurse cell chromatin (data not shown).  
The increase in H3K9me3 at heterochromatin in cells overexpressing dADD1 
may also contribute to the increased HP1a recruitment to heterochromatin, as the 
chromo-domain of HP1a binds to H3K9me3. This possibility needs to be tested, but 
first the dADD1-HP1a interaction motif needs to be identified. Once the dADD1-
HP1a interaction domain is identified a fly line can be generated that contains an 
inducible dADD1 construct with a mutated HP1a binding site. Recruitment of HP1a 
to heterochromatin between the dADD1-GFP and dADD1-HP1a binding mutants 
could be compared and levels of H3K9me3 at heterochromatin also monitored. If 
HP1a is recruited to heterochromatin at similar levels in the dADD1-GFP and 
dADD1-HP1a binding mutant, and H3K9me3 levels are not effected in the mutants, 
then the increase in HP1a is likely the result of increased heterochromatic H3K9me3 
recruiting HP1a and not the result of a direct interaction between dADD1 and HP1a.  
To better understand if the observed increases in HP1a, H3.3 or H3K9me3 in 
dADD1-overexpressing cells represented a total cellular increase or simply over-
recruitment of available proteins, we tested the total cellular level of these factors in 
S2 cells overexpressing dADD1 by western blot. Total cellular levels of HP1a 
remained unchanged in dADD1 overexpressing S2 cells, while levels of both H3.3 
and H3K9me3 increased in comparison to control S2 cells. This indicated that the 
increased recruitment of HP1a to heterochromatin in follicle cells overexpressing 
dADD1 is the result of recruitment of available HP1a and not the result of increased 
HP1a expression. However, the increased protein levels of H3.3 indicate a 
transcriptional increase in H3.3 in cells overexpressing dADD1. An increase in 
cellular H3K9me3 would be expected if overexpression of dADD1 increased the 
recruitment of Eggless to heterochromatin, which would bring more H3K9 tri-
methylases in proximity of their target substrates.  
As Bonus was able to recruit dADD1 to euchromatin in cells overexpressing 
Bonus, we also tested if dADD1 was able to recruit Bonus to heterochromatin in 
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dADD1 overexpressing cells. In wildtype follicle cells, Bonus is excluded from 
heterochromatin, but in follicle cells overexpressing dADD1 Bonus was enriched at 
dADD1-rich heterochromatin. This demonstrated that Bonus and dADD1 are 
somehow able to recruit one another to chromatin. However, we also observed HP1b 
recruitment to both euchromatic Bonus foci in Bonus-overexpressing cells and to 
dADD1-rich heterochromatin in dADD1-overexpressing cells, opening up the 
possibility that the reciprocal recruitment of dADD1 and Bonus may be facilitated 
through HP1b.  
4.3 Model 
Here we show that dADD1 and XNP are multifaceted chromatin-associated 
proteins that have many functions at chromatin. Both proteins interact with 
heterochromatin associated proteins such as HP1a, but also with euchromatic 
proteins such as HP1b. Common interaction partners implicate dADD1 and XNP in 
the regulation of telomeres and transposon sequences and suggest that dADD1 and 
XNP may be important for repair of DNA double-strand breaks.  
Based on the knowledge garnered in this thesis, we suggest the following 
models for how dADD1 and XNP function at heterochromatin, euchromatin and in 
the repair of double strand DNA breaks (Figure 31).  
At heterochromatin, both dADD1 and XNP associate with HP1a, and this 
interaction helps to recruit both proteins to heterochromatin. However, dADD1 is 
also recruited to heterochromatin through the ADD-domain binding to H3K9me3. 
Both proteins are likely required for the deposition of H3.3. Specifically, we show 
that dADD1 and XNP interact with H3.3 and that overexpression of dADD1 leads to 
increased H3.3 incorporation into heterochromatin. XNP has previously been shown 
be important for incorporation of H3.3 into chromatin so it is possible that XNP aids 
in H3.3 deposition at both heterochromatin and euchromatin, but more work needs 
to be done to determine if XNP is generally necessary for H3.3 deposition [53].  
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Figure 31: Model of dADD1 and XNP chromatin associated functions. 
dADD1 and XNP are recruited to heterochromatin through interaction with HP1a, however, dADD1 is 
additionally recruited through ADD domain binding to H3K9me3. Both proteins interact with H3.3 and 
aid in deposition of this histone variant into chromatin. dADD1 recruits Eggless to heterochromatin 
where it tri-methylates H3K9, aiding in further recruitment of dADD1 and HP1a. dADD1 and XNP also 
play a role in regulation of telomeric heterochromatin where dADD1 interacts with Pzg, Chro and 
Prod, while XNP interacts with Pzg. At euchromatin dADD1 interacts with HP1b and Bonus and XNP 
interacts with HP1b. It is possible that HP1b and dADD1 bind specific histone methylation marks 
aiding in protein recruitment, however, if these marks are H3K9me3 needs to be shown. dADD1 and 
XNP are also involved in double strand DNA break repair where dADD1 and possibly XNP interact 
with members of the Tip60 DNA repair complex members Pontin, Reptin and H2Av. Here dADD1 and 
XNP may aid in the replacement of g-H2Av with un-phosphorylated H2Av. 
 
Based on dADD1 overexpression data and that dADD1 interacts with the 
H3K9 tri-methylase Eggless, it is likely that dADD1 recruits Eggless to 
heterochromatin and this results in tri-methylation of H3K9. This in turn can lead to 
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increased recruitment of HP1a and dADD1 to heterochromatin resulting in a self-
sustaining recruitment loop.  
dADD1 also significantly interacts with the telomeric associated proteins 
Prod, Chro and Pzg suggesting dADD1 may be important for regulation of 
telomeres. XNP interacts with the protein Pzg, which has been shown to be 
associated with telomeres, but is also important for general chromatin compaction at 
target DNA [77]. Although we identify here these new interaction partners, further 
work needs to be undertaken to validate these interactions and investigate the 
telomeric associated function of these proteins.  
At euchromatin, both dADD1 and XNP likely interact with HP1b and this 
may be one of the ways in which these proteins are recruited to euchromatin. It is 
believed that the chromo-domain of HP1b binds to H3K9me3 similar to the chromo-
domain of HP1a, although no work has been done to investigate HP1b-H3K9me3 
binding. Since H3K9me3 very specifically localizes to heterochromatin and HP1b 
localizes to euchromatin we suggest the possibility that HP1b may bind a currently 
unknown combination of H3K9me histone tail modifications at euchromatin. 
dADD1 also interacts with Bonus at euchromatin, where Bonus, dADD1 and 
HP1b associate at Bonus rich foci. Through overexpression experiments we showed 
that both dADD1 and Bonus are capable of recruiting one another, as well as HP1b, 
to dADD1 and Bonus enriched chromatin regions. The exact mechanism and order 
of recruitment is still unknown but further work should be undertaken to better 
understand the nature of this interaction and the function of this complex at 
euchromatin.  
Repair of damaged DNA is an essential cellular process. Through our MS 
analysis, dADD1 was found to significantly interact with the Tip60 complex 
members Pontin, Reptin and H2Av, while XNP was shown to interact significantly 
with H2Av and possibly also with Pontin and Reptin. Experiments testing dADD1 
and XNP homozygous mutants for their ability to repair double-strand DNA breaks 
showed that both mutants had an impaired resolution of g-H2Av, a marker of 
double-strand DNA breaks, at nurse cell chromatin of females treated with 
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hydroxyurea. The Tip60 complex is involved in repair of double-strand DNA breaks, 
with part of the complex functioning to replace g-H2Av with un-phosphorylated 
H2Av. Based on the interaction of dADD1 and XNP with H2Av it is possible that 
these proteins are involved in histone turnover at sites of DNA damage.  
While dADD1 and XNP interact with similar proteins and have similar 
functions we do not observe an interaction between the two proteins. Therefore, our 
model does not include any direct protein interactions. The model presented here 
provides a foundation for further studies into the role that these two proteins play at 
specific chromatin regions and identifies many complexes that may mediate 
chromatin specific functions of dADD1 and XNP.  
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5 Conclusion  
Maintenance of chromatin is very important for proper organism health and 
development. Misregulation or mutations within chromatin regulatory proteins 
underlie many human diseases such as cancer, neurological disorders, 
cardiovascular diseases and autoimmune diseases. ATRX syndrome, which causing 
learning and memory defects is one such disease that results from mutations within 
the protein ATRX with over 80% of mapped disease causing mutations falling within 
either the chromatin binding ADD domain or the chromatin remodeling SNF2 
domain.  
The ADD and SNF2 domain of ATRX map to two independent proteins in 
Drosophila, dADD1 and XNP. These domains show a high degree of sequence 
conservation to the human sequence and loss of these proteins in Drosophila results 
in similar phenotypes to ATRX mutants. These phenotypes include learning and 
memory defects, impaired DNA damage responses as well as defective transposon 
silencing, suggesting functional conservation of these proteins.  
While the ADD and SNF2 domain of ATRX were split into two proteins in 
Drosophila we did not observe a direct interaction between dADD1 and XNP. We did 
however, identify a number of shared interaction partners, suggesting that while 
these proteins do not function together directly, they do function in shared pathways 
and have similar biological functions. This notion is further supported by the 
exacerbation of mutant phenotypes in combination. 
 
C o n c l u s i o n  
90 
There is still much to learn about the role that dADD1 and XNP play at 
chromatin and how these proteins function at both heterochromatin and 
euchromatin. Here we identified a number of new functions of dADD1 and XNP at 
chromatin, and have laid the foundation for the understanding of the role that these 
two proteins play in maintaining genomic stability and integrity.  
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6 Materials and Methods 
6.1 General cell culture 
6.1.1 Counting cells 
Cells were counted using the Millipore Scepter Cell counter with 60 µm 
Sensors. Before counting cells were diluted 1/10 in TBS.  
6.1.2 Freezing insect cell lines 
Insect cell lines were frozen in Freezing Media containing 70% serum free 
media (Scheniders Medium for S2 cells and Sf-900TM II Medium for Sf21 cells), 20% 
FBS and 10% DMSO. When cells were growing optimally a culture of cells at 
aproximately 5 x 106 cells/ml was spun down at 500 x g for 5 minutes and the 
supernatant was discarded. The cells were then re-suspended in ¼ of the initial 
culture volume in Freezing Media and 500 µl of cells were aliquoted into cryovials. 
Initially the cells are frozen for 2-3 days at -80°C before being transferred to a liquid 
nitrogen freeze for long term storage.  
6.2 S2 cell culture 
6.2.1 Culturing conditions 
All S2 derived cell lines were cultured in serum free Schneiders Medium 
supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-Glutamine (L-Glut) and 
1% Penicillin-Streptomycin (P/S). For optimal growth, cells were split every 4-5 days 
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and for maintenance cells were split every 1.5-2 weeks. Cells were cultured in 
ventilated flasks at 25°C. For splitting cells were detached from the bottom of the 
flask using a rubber cell scraper. To break up cell clumps cells were pipet up and 
down 5-10 times against the bottom of the flask using a pipetman before being 
transferred to a new flask with fresh media. Normal splitting ratios were between 
1/3 and 1/10 depending on the frequency of experiments and the density of cells.  
Stable cells were cultured in supplemented Schneiders Medium containing 
hygromycin at a final concentration of 0.1 µg/µl. 
6.2.2 Transfection 
For transfections cells were split to 70-80% confluency a minimum of 2 hours 
before transfection. S2 cells were transfected using Roche X-tremeGENE transfection 
reagent. A master mix was incubated for 15-30 minutes at RT that contained serum 
free Scheneiders Medium, 1/10th the volume of cell culture to be transfected  (e.g. 3 
ml of cells to be transfected = 300 µl serum free media), plasmid diluted to a 
concentration of 0.01 µg/µl in the master mix and 2 µl of transfection reagent per 100 
µl of master mix volume. After incubation master mix was added to the cells and left 
overnight before inducing protein expression.  
6.2.3 Stable cell line generation 
Stable cells were generated by transfecting S2 DRSC cells with plasmids 
containing a hygromycin resistance marker. Cells were split to 70-90% confluency 
into 6 well plates in a total of 3 ml of media and allowed to settle for a minimum of 2 
hours before transfection. After transfection cells sat for 2 days at 25°C before being 
split 1/10 into small ventilated flasks in 3 ml of media with added hygromycin to a 
final concentration of 0.1 µg/µl. Cells were monitored and split every 4-10 days, as 
necessary to maintain selection pressure.  
6.2.4 RNAi 
The number of cells was measured using the Scepter Cell Counter as 
described above (See 6.1.1 Counting cells). Remaining cell culture was collected in a 
falcon and spun at 700 x g for 10 minutes. Media was removed and cells were re-
suspended in serum free Schneiders media to a concentration of 1-2 x 106 cells/ml. 
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One ml of re-suspended cells were plated into a single well of a 6 well plate and 
allowed to settle for 30-60 minutes at 25°C before adding 10 µg of dsRNA. After 
addition of dsRNA cells were swirled very gently for 10 minutes at RT then placed 
back at 25°C for 50 minutes. After 50 minutes 2 ml of supplemented Schneiders 
Media was added to each well. The plates were sealed with parafilm to prevent 
evaporation and then left for 4-7 days at 25°C.  
6.2.5 Whole cell lysis 
S2 cells were collected and spun down at 700 x g for 5-10 minutes at RT. The 
media was discarded and cells were lysed in an appropriate volume of cell lysis 
buffer [20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 10 
mM PMSF, Roche Mini Complete protease inhibitor cocktail]. After lysis cells were 
spun at 6 000 x g for 3 minutes at RT to remove cellular debris. The supernatant was 
transferred to a new tube and either prepared directly for western blot by adding 4 x 
Laemmli buffer to a final concentration of 1 x followed by boiling at 95°C for 5 
minutes, or were used in immunoprecipitations (See 6.4.3 Immunoprecipitation). 
Proteins were either loaded directly onto an SDS gel or were stored at -20ºC. 
6.2.6 Salt nuclear extraction 
Cells were collected by spinning 700 x g for 5 minutes at RT. The supernatant 
was discarded and the cells re-suspended in A+NP buffer [15 mM NaCl, 15 mM Tris-
HCl pH 8.0, 13 mM EDTA, 60 mM KCl, 0.5% NP-40, 0.1% BME, 10 mM PMSF, Roche 
Mini Complete protease inhibitor cocktail, PhosSTOP phosphatase inhibitor]. Re-
suspended cells were then drawn 10x through a 27 gage needle to destroy the outer 
cell membrane and then spun for 5 minutes at 300 x g at 4°C to remove cellular 
debris. After spinning the supernatant was transferred to a new tube and spun for 10 
minutes at 6 000 x g at 4°C to pellet the nuclei. The remaining supernatant was 
transferred to a new tube and either discarded or prepared for loading onto an SDS 
gel, while the pellet containing the nuclei was lysed with RIPA buffer. Samples were 
then treated as was necessary for the following experiment. 
6.2.7 Triton nuclear extraction 
For Triton nuclear extraction cells were collected by spinning at 700 x g for 5 
minutes at RT. The supernatant was discarded and cells were re-suspended in Triton 
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extraction buffer [1 x PBS, 0.3% Triton X-100, 10 mM PMSF, Roche Mini Complete 
protease inhibitor cocktail] and drawn 10 x through a 27 gage needed to disrupt the 
outer cellular membrane. Cells were then spun at 300 x g for 5 minutes at RT to 
remove cellular debris. The supernatant was then transferred to a new tube and 
spun for 10 minutes at 6 000 x g at 4°C to pellet the nuclei. After spinning the 
supernatant was transferred to a new tube and RIPA buffer was added to the 
nuclear pellet to disrupt the nuclear membrane. Laemmli buffer was added to both 
the supernatant and nuclear fractions to a final concentration of 1 x and the samples 
were boiled for 5 minutes at 95°C with vortexing and stored at -20°C before running 
on a western blot. 
6.3 HELA Kyoto cell culture 
6.3.1 Culturing conditions 
HELA Kyoto cells were cultured at 37°C with CO2 in serum free Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% FBS and 1% P/S. Cells 
were maintained in 10 cm plates in 10 ml of media and were split every 2-3 days. For 
splitting cells were rinsed twice with PBS, then trypsinized in 500 µl of trypsin to 
detach cells from the plate. Trypsinized cells were then re-suspended in 10 ml of 
fresh media and were pipet against the bottom of the plate until cells reached a 
single cell suspension. One ml of this single cells suspension was then transferred to 
9 ml of fresh media in a new plate.  
6.3.2 Transfection 
For transfections HELA Kyoto cells were split to 70-90% confluency into 8 
well IBIDI slides containing a final volume of 200 µl and allowed to settle for a 
minimum of 2 hours before transfection. Cells were transfected with Lipofectamine 
3000. To begin two separate master mixes were prepared that contained per well 1) 
12.5 µl OptiMEM, 0.25 µg Plasmid and 0.5 µl of P3000 or 2) 12.5 µl OptiMEM and 
0.75 Lipofectamine 3000. These two master mixes were left for 10-15 minutes at RT 
before mixing together and waiting another 10-15 minutes. After the second 
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incubation the combined master mix was added to the cells before placing back in 
the incubator over night.  
6.4 Protein expression, purification and detection 
6.4.1 S2 cell protein expression 
Proteins were expressed in S2 cells either by transiently transfecting cells 
with plasmids or by generating stable cells. Plasmids used in this thesis were under 
the control of the metallothionine promoter, which is a heavy metal inducible 
promoter. To this end we induced protein expression through the addition of copper 
sulphate (CuSO4) to a final concentration of 0.2 mM for 24 hours. After protein 
expression cells were collected and lysed as above (See 6.2.5 Whole cell lysis). 
6.4.2 Ovary, brain and imaginal disc protein extraction 
Proteins were extracted from Drosophila tissue for western blot analysis. For 
ovaries females were fatted on yeast paste for 2 days with males before dissection. 
Brains were taken from both adult and 3rd instar larvae and imaginal discs were 
removed from 3rd instar larvae. All dissections took place in PBS. After dissection 
tissues were transferred to cell lysis buffer [20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 
mM EDTA, 0.5% Triton X-100, 10 mM PMSF, Roche Mini Complete protease 
inhibitor cocktail] and pipet vigorously for 30 seconds to lyse the tissues. Lysates 
were then spun at 6 000 x g for 3 minutes to remove cell debris. Supernatant was 
then transferred to a new tube and 4 x Laemmli was added to a final concentration 
of 1 x before boiling samples at 95ºC for 5 minutes. Samples were either directly 
loaded onto an SDS gel or were stored at -20ºC.   
6.4.3 Immunoprecipitation 
Cell lysates from S2 cells and Sf21 cells were used to further purify proteins 
of interest (See 6.2.5 Whole cell lysis and Error! Reference source not found. Error! 
Reference source not found.). For immunoprecipitations with Protein G beads from 
GE healthcare cell lysates were incubated overnight at 4ºC with 1º antibodies. 
Protein G beads or Flag M2 beads from Sigma were pre-blocked in 3% bovine serum 
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albumin (BSA)-TBS for 1 hour at 4ºC before adding cell lysate to the beads and 
incubating 2 hours at RT. After incubation beads were washed quickly 3 x with TBS 
and proteins were eluted from the beads by boiling at 95ºC for 5 minutes in 1 x 
Laemmli buffer with vortexing. Beads were then spun for 30 seconds at 6 000 x g and 
supernatants were transferred to a new tube and either loaded directly onto an SDS 
gel or were frozen at -20ºC.  
6.4.4 Measuring protein concentration 
When necessary, protein concentration was measured using Pierce 660 nm 
Protein Assay Reagent. In a 96 well microplate 10 µl of cell lysate and 10 µl  of 
proteins standards were mixed with 150 µl of Protein Assay Reagent. OD readings 
were taken with at 660nm. Protein concentration was calculated in excel by plotting 
OD of cell lysis sample on the graph generated using the protein standards.  
6.4.5 Western blotting 
SDS gels were prepared using the BioRad Mini-PROTEAN casting system. 
Cast gels were loaded into the Mini-PROTEAN Tetra Tank and run at 100-200V until 
desired separation was reached. Proteins were then wet blot transferred to a 
nitrocellulose membrane. Wet blotting was performed at 300mA either at 4ºC or on 
ice until proteins were transferred to the membrane (1-3 hours). Membranes were 
blocked in 3% BSA-0.5%TBS-Tween (TBST) for 15 minutes before 1º antibodies were 
added and incubated with the membrane overnight at 4ºC. After 1º incubation 
membranes were rinsed 3 x quickly in 0.5%TBST and then 3 x 15 minutes. 
Membranes were again blocked in 3% BSA-0.5%TBST and 2º antibodies were added 
for 2 hours at RT. Following 2º antibody incubation membranes were rinsed 3 x 
quickly in 0.5%TBST and then 3 x 10 minutes.  
For horse radish peroxidase coupled 2º antibodies, membranes were 
incubated for 1-2 minutes with ECL Western Blotting Substrate from pierce and then 
imaged with a BioRad Chemidoc. Blots were overlapped with the ladder and 
adjusted with Photoshop.  
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6.5 Fly Husbandry 
All flies and crosses were kept on standard food and raised at room 
temperature. dADD12, XNP403 and XNP406 were isoginized to the Iso31 background 
over 10 generations to remove any possible background mutations. Alleles were 
followed by single fly PCR using the following primers received as a personal 
communication from Dr. Kami Ahmad:  
dADD1-F 5’- AACTCGATATGTTTATACGGTCTC -3’  
dADD1-R-5’-GATGTCACGGATGTAATCTTCA -3’ 
XNP-F-5’- TTCGAACTTAACTGAGTTGACG -3’  
XNP-R-5’- AAATGTGGCGAGCCCCGTGA -3’.  
For pupal survival, egg lays were performed for 6 hours at room temperature 
on grape plates with additional yeast paste. Eggs were kept at 25°C overnight and 
first instar larvae were transferred to new vials the following day. Pupae were 
counted before eclosion and ecolosed adults were counted. For melanotic tumor 
incidence crosses were flipped daily onto new food and egg lays were kept at 25°C 
until eclosion. After eclosion remaining flies were anaesthetized with CO2 and placed 
into isopropanol until they were scored. Pictures of females were taken using a Leica 
Z 6 Apo macroscope with 1.25 x objective and processed using HeliconFocus.  
6.6 Immunofluorescence 
6.6.1 Imaginal discs 
Wandering 3rd instar larvae were dissected in PBS leaving the imaginal discs 
attached to the cuticle. Discs were fixed for 5 minutes in 4% PFA in 0.01% PBS-Triton 
X-100 and were rinsed 3 x in 0.1% PBST before blocking for 20 minutes in 5% NGS-
0.1% PSBT. Antibodies were added to the blocking solution and samples were 
incubated overnight at 4°C. Following 1° antibody staining discs were rinsed 3 x 
quickly in 0.1% PBST and then for 3 x 10 minutes before being blocked in 5% NGS-
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0.1% PSBT. DAPI, Phalloidin and appropriate secondary antibodies were added to 
the blocking solution and incubated for 2 hours at RT before 3 x quick rinse in 0.1% 
PBST followed by 3 x 10 minutes. Following the final wash cuticles were transferred 
to PBS in a dissection dish and the appropriate imaginal discs were fine dissected 
and then mounted on microscope slides with antifade.  
6.6.2 Adult Brains 
Adult flies were anaesthetized with CO2 before being transferred to a 
dissection dish with PBS. Brains were fixed in 4% PFA-0.3% PBST for 20 minutes at 
RT, followed by blocking in 0.3% PBST with 5% Normal Goat Serum. Brains were 
left in blocking solution and rotated with primary (1º) antibodies for two overnights 
at 4°C. Brains were washed 3 x 20 minutes at RT in 0.3% PBST. Secondary (2º) 
antibodies were added to the samples and incubated for a total of 4 hours at RT in 
the blocking solution. During the final hour of secondary incubation DAPI and 
phalloidin were added. Samples were again washed 3 x 20 minutes in 0.3% PBST 
before mounting. 
6.6.3 Larval Brains 
Third instar larvae were transferred to a dissection dish with PBS. Brains 
were dissected and fixed in 2% PFA-PBL [1mM Lysine-HCl, 12mM Disodium 
Phosphate, PBS] for 15 minutes at RT. Samples were blocked in 0.5% PBST with 10% 
Normal Goat Serum for 15 minutes followed by primary antibody incubation 
overnight at 4°C. Samples were then washed 3 x 5 minutes in 0.5% PBST and 
incubated with secondary antibodies, phalloidin and DAPI for 2-3 hours at RT. 
Samples were the washed 2 x 15 minutes in 0.5% PBST and 2 x 15 minutes in PBS 
before mounting.  
6.6.4 Ovaries 
Young females and males were put together on yeast paste to fatten up for 2 
days before dissection. Flies were anesthetized with CO2 and females were dissected 
in a dissection dish containing PBS. Ovaries were removed from fattened females 
and fixed for 5 minutes in 4% PFA-PBS then rinsed twice in 0.5% PBS-Triton-X-100 
(PBST). Primary antibodies were added to 0.5% PBST and samples were incubated 
overnight at 4ºC. Samples were then quickly rinsed twice with 0.5% PBST and then 
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for 3 x 15 minutes. After washing samples were incubated with necessary fluorescent 
dyes and 2º antibodies for 2 hours at RT. Samples were again rinsed quickly twice 
with 0.5% PBST and then for 3 x 10 minutes. When washing was complete ovaries 
were dissociated using a P200 pipet, allowed to settle and then mounted on slides in 
Antifade solution. Finally, to prevent evaporation the edges of the cover slip was 
sealed with nail polish. All incubation steps were preformed on a nutator. 
For dADD1 antibodies samples were blocked with 5% normal goat serum 
(NGS) in 0.5% PBST before and during 1º and 2º antibody stainings. 
6.6.5 S2 Cells 
8 well IBIDI plates were coated with Poly-L- Lysine for 30 minutes and then 
rinsed with sterile water. S2 cells were then plated into each well to a confluency of 
between 70-90% and the cells were allowed to adhere for a minimum of 2 hours 
before transfection. Transfections were performed as described in 6.2.2 Transfection 
and after an overnight incubation protein expression was induced by adding CuSO4 
to a final concentration of 0.2 mM for 24 hours. After induction cells were fixed for 
15 minutes in 2% PFA by adding PFA directly to the cell culture media being careful 
not to dislodge the cells from the bottom of the well. The fixative was removed and 
cells were washed 3 x in 0.02% PBST and then incubated for 10 minutes at RT in 
0.02% PBST to permiabilize the membranes. Samples were then blocked for 20 
minutes in 5% NGS-0.02% PBST, 1° antibodies were added to the blocking solution 
and incubated overnight at 4°C. Cells were rinsed 3 x quickly and then 3 x 10 
minutes in 0.02% PBST before blocking again in 5% NGS-0.02% PBST. DAPI, 
Phalloidin and 2° antibodies were added to the blocking solution and incubated at 
RT for 2 hours in the dark. 2° antibodies were removed, cells were rinsed 3 x in 
0.02% PBST and 3 x 10 minutes. Samples were stored in the fridge in PBS with 1/1000 
sodium azide before imaging.  
6.6.6 HELA Kyoto Cells 
Cells were transfected with mammalian expression vectors containing a 
CMV promoter with a C-terminal GFP tag. Proteins were expressed for 16-24 hours 
before being rinsed quickly with PBS and then fixed for 10 minutes in 4% PFA-PBS. 
At the end of 10 minutes a drop of 0.02% PBST was added to the fixation solution 
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(recommendation from Dr. Irina Solovei to preserve chromatin structure). The PFA 
was then removed and the cells were rinsed twice with 0.02% PBST then for 20 
minutes to permiabilize the cells. After permiablization cells were blocked for 20 
minutes in 5% NGS-0.02% PBST, antibodies were added and cells were incubated 
overnight at 4ºC. Following 1º antibody staining, cells were rinsed twice with 0.02% 
PBST and then 3 x 10 minutes at RT. Cells were again blocked in 5% NGS-0.02% 
PBST for 20 minutes before adding DAPI, phalloidin, a-GFP 488 Nano-Booster from 
ChromoTek and appropriate 2º antibodies for 2 hours. After incubation cells were 
rinsed twice in 0.02% PBST and then 3 x 10 minutes. For storage cells were covered 
with a 0.25% Antifade-PBS solution containing a 1/1000 dilution of sodium azide 
(NaN3) and kept in the dark at 4ºC before imaging.  
6.7 Nucleic acid techniques 
6.7.1 Plasmid purification 
Plasmids were purified from bacteria grown on LB agar plates with 
appropriate antibiotics for 24 hours at 37°C. Single colonies were then selected and 
grown overnight at 37°C with shaking in liquid LB media containing the appropriate 
antibiotics in 5 ml volume for mini preparations and 100 ml volume for midi 
preparations. Following amplification plasmids were extracted using the NucleoSpin 
Plasmid DNA purifiaciton kit from Machery-Nagel following the company 
instructions. Plasmids were verified through test digestions with restriction enzymes 
and then sent for sequencing.  
6.7.2 Gateway cloning 
cDNA was PCR amplified from plasmids or from cDNA with primers 
containing restriction enzyme recognition sites. PCR products were digested with 
restriction enzymes and then column purified using NucleoSpin Gel and PCR Clean-
up kit from Machery-Nagel. The pENTR- AttR vector was digested, run out on an 
ethidium bromide gel and the backbone was gel purified. PCR products were ligated 
together with the pENTR-AttR backbone to generate pENTR-cDNA vectors. To 
generate AttR/L expression vectors recombination reactions were performed 
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containing the appropriate destination vectors and pENTR vectors. Recombination 
reactions were performed using the Gateway LR Clonase II Enzyme mix following 
the kit instructions, but using half of the reaction volume and components. Plasmids 
were then transformed into bacteria, selected on LB plates containing antibiotics and 
plasmids were purified as described in 6.7.1 Plasmid purification.  
6.7.3 Rolling circle PCR 
Rolling circle PCR was used to generate amino acid mutants and to insert 
short protein tags or other special features onto plasmids. Primers were designed so 
that the 5’ ends bordered on one another but bound to complementary strands and 
amplified in opposite directions. Amino acid substitutions were induced by 
nucleotide substitutions that caused amino acid changes during translation, while 
the addition of tags (e.g. Flag) or other special features (e.g. TEV cleavage site) were 
inserted through overhangs on the primers. Target sequences were amplified as a 
linear fragment and the PCR reaction was digested with DpnI for 1 hour at 37°C to 
remove plasmid DNA. The PCR product was run on a gel to test for the correct size 
and then gel purified. Purified product was then treated with PNK kinase with 
added ATP to phosphorylate the 5’ DNA ends and then column purified to remove 
the PNK before ligation to re-circularize the plasmid. Plasmids were then 
transformed into bacteria and the purified as described in 6.7.1 Plasmid purification 
and were then used for injections. 
6.7.4 gDNA extraction 
Genomic DNA was prepared from S2 cells, imaginal discs or whole larvae. 
Samples were lysed in 400 µl lysis buffer A [100 mM Tris-HCl pH 7.5, 100 mM 
EDTA, 100 mM NaCl, 0.5% SDS] and then incubated for 30 minutes at 65°C. After 
incubation 800 µl of 1 part 5 M potassium acetate (KAc) 2.5 parts 6 M lithium 
chloride (LiCl2) were added and samples were precipitated on ice for 10 minutes 
then spun at 15 000 x g for 15 minutes at 4°C. Supernatant was separated into two 
new Eppendorf tubes and 700 µl of isopropanol was added per 1 000 µl of 
supernatant. The two tubes were spun 15 000 x g for 15 minutes at 4°C, the the super 
natant was removed and the pellet was washed with 1 ml of cold ethanol before 
being again centrifuged at 15 000 x g for 5 minutes at 4°C. Following the final spin 
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the supernatant was removed and the pellet was allowed to briefly dry before being 
re-suspended in TE buffer.  
6.7.5 RNA extraction 
6.7.5.1 TRIzol RNA extraction 
Ovaries from 10 females that had been fattened on yeast paste for at least 2 
days were dissected before adding 1 ml of TRIzol. The tissue was then homogenized 
using a pipette and incubated at RT for 5 minutes. Following the incubation 200 µl of 
chloroform and 10 µg of glycogen were added to the samples. Samples were shaken 
by hand and incubated for 2-3 mins at RT then transferred to a gel-lock tube and 
then spun for 5 minutes at 12 000 x g at 4°C. The top aqueous phase was removed 
and precipitated with 500 µl isopropanol for 5-10 minutes at RT and then again spun 
at 12 000 x g for 10 minutes at 4°C. The supernatant was removed and the pellet was 
washed with 75% ethanol and then spun again at 7 500 x g for 5 minutes. Following 
the final spin the ethanol was removed and the pellet was allowed to dry briefly 
before re-suspending in DEPC water.  
6.7.5.2 Turbo DNAse treatment 
Contaminating DNA was removed from the RNA extractions with DNAse 
treatment. 2 µg total RNA was incubated with 1 µl 10X Turbo DNA free reaction 
buffer and 1 µl of TurboDNAse for 30 minutes at 37°C. After incubation 2 µl of milk 
was added to block the reaction and left at 25°C for 5 minutes. Samples were spun 
for 1.5 minutes at 10 000 x g and the supernatant was transferred to a cDNA reaction 
tube. The clean RNA was diluted in 4 µl of water and analyzed on the Bioanalyzer 
for purity. 
6.7.6 cDNA preparation 
cDNA was prepared using the Superscript III reverse transcriptase kit. The 
following PCR reaction was set up on ice: 
• 10 µl 2X reaction mix 
• 2 µl RT enzyme mix 
• 8 µl RNA  
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These samples were then incubated in the PCR machine at 25°C for 10 
minutes, 50°C for 30 minutes, 85°C for 5 minutes and the 4°C indefinitely. 1 µl of 
RNAse H was then added to digest away the remaining RNA and the samples were 
incubated for 20 minutes at 37°C. Following RNAse H treatment the cDNA was 
diluted in 200 µl of water.  
6.7.7 RT-qPCR 
For a single well the following reactions were prepared using the Power 
SYBR Green PCR Master Mix from AppliedBiosystems:  
• 5 µl PCR Mix 
• 4 µl cDNA template 
• 0.5 µl Primer 1 
• 0.5 µl Primer 2 
• 0.6 µl water 
Reactions were prepared in triplicate and ct values were averaged and then 
normalized to an average ct value from 4 different housekeeping genes using the 
DDCt method [78].  
6.7.8 dsRNA 
dsRNA was generated for cell culture RNAi knockdown. DNA was 
amplified from cDNA plasmids using primers containing T7 Polymerase promoters 
on the 5’ end of each primer. PCR reactions were column purified and dsRNA was 
generated using the HiScribe T7 Quick High Yield RNA synthesis kit as per 
company instructions. 
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6.8 Materials 
6.8.1 Fly stocks 
 
6.8.2 Cell Lines 
 
Internal Reference 
Number
Description Source
AC0806 CG8290 [2] / CG8290 [2] Dr. Mitzi Kuroda
AC0816 CG8290-BioTAP #8 Dr. Mitzi Kuroda
AC0817 CG8290-BioTAP #9 Dr. Mitzi Kuroda
AC0812 CG8290 [2] iso31/CyO, ubi-GFP ; XNP [403] iso31/TM6c Isoginized this study
AC0813 CG8290 [2] iso31/CyO, ubi-GFP ; XNP [406] iso31/TM6c Isoginized this study
AC0808 CG8290 [2] iso31/CyO, ubi-GFP Isoginized this study
AC0809 CG8290 [2] iso31/CG8290 [2] iso31 Isoginized this study
-- UAS dADD1-GFP/TM6c This Study
-- dADD1 endoGFP Bloomington Stock Center (BL 52172)
AC0825 w ; xnp[403] / TM3-GFP Dr. Kami Ahmad
AC0826 w ; xnp[406] / TM3-GFP Dr. Kami Ahmad
AC0827 XNP [403] iso31/TM6c Isoginized this study
AC0829 Sp/ CyO, ubi-GFP; XNP [403]/TM6c iso31 Isoginized this study
-- XNP [403] iso31/XNP [403] iso31 Isoginized this study
AC0831 XNP [406] iso31/TM6c Isoginized this study
AC0832 Sp/ CyO, ubi-GFP; XNP [406]/TM6c iso31 Isoginized this study
AC0834 UAS-XNP.HA / III Bloomington Stock Center (BL26645)
AC0847 UAS-Bon-RFP [Hto-QYE] Bloomington Stock Center (BL56534)
AC0002 iso 31 Dr. Annette Schenck
AC0046 hsflp [122];  FRT42D /CyO, ubi-GFP; Dr /  TM6c Dr. Anne Classen
AC0121 Act5C-Cas9, Lig4 [?] ; Sco/CyO Dr. Frank Schnorrer
AC0167 Pin[1]/CyO; nSyb-GAL4, UAS mCD8::GFP Dr. Ilona Kadow
AC0190 TJ-GAL4, Mef20-GAL80/CyO Dr. Sally Horne Badovinac
AC0366 DE Cad::dTomato/CyO Bloomington Stock Center (BL 58789)
AC0403 Sp/CyO;  hp1:GFP-HP1/TM6c Bloomington Stock Center (BL30561)
AC0721 FRT42D Psc-Su(z)2[XL26]/ CTG Dr. Anne Classen
Cell Line Derivative Plasmid Intigration Source
Schneider 2 (S2) Drosophila melanogaster embryo -- Dr. Axel Imhof
S2 DRSC S2 Cells -- Dr. Axel Imhof
Sf21 Spodoptera frugiperda  Ovaries -- Dr. Catherine Regnard
HELA Kyoto Human Cervival Cancer Cells -- Dr. Heinrich Leonhardt
Cas9 S2 Cells Act5c Cas9 Dr. Frank Schnorrer
dADD1-Flag/HA S2 Cells pMT-dADD1-RA-Flag/HA Dr. Andreas Thomae
Psc 1-911 WT S2 Cells pMT-Psc 1-911 WT-Flag/HA This study
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6.8.3 Antibodies 
6.8.3.1 Primary Antibodies 
 
6.8.3.2 Secondary Antibodies 
 
 Primary Antibodies Source Animal Western Blot Immunofluorescnce
Bonus Dr. Hugo Bellen Guinea Pig 1/500 1/100
dADD1 Dr. Andreas Thomae Rat 1/20 1/20
Flag Dr. Elizabeth Kremmer Rat 1/200 --
Flag M2 Sigma Mouse 1/1000 1/500
GFP ImmunoKontakt Rabbit 1/5000 1/1000
H3 abcam Rabbit 1/5000 --
H3.3 abnova Mouse 1/500 1/100
H3K9me3 abcam Rabbit 1/500 1/200
HA Dr. Elizabeth Kremmer Rat 1/200 1/20
HA Roche Mouse -- 1/200
HP1a DSHB Mouse 1/200 1/200
HP1b Dr. Axel Imhof Rat 1/20 1/20
JNK Santa-Cruz Rabbit 1/5000 --
Myc Roche Mouse 1/1000 1/500
Myc Dr. Elizabeth Kremmer Rat 1/500 1/100
p-JNK Promega Rabbit 1/5000 --
Psc 39 Dr. Elizabeth Kremmer Rat 1/20 1/10
Psc 77 Dr. Elizabeth Kremmer Rat 1/50 1/10
Psc 78 Dr. Elizabeth Kremmer Rat 1/20 1/10
Psc 79 Dr. Elizabeth Kremmer Rat 1/20 1/10
Psc 8C8 Dr. Elizabeth Kremmer Rat 1/20 1/10
Tubulin Sigma Mouse 1/5000 --
XNP Dr. Kami Ahmad Rabbit -- 1/8000
Protein-A Sigma Rabbit 1/500 1/1000
Secondary Antibodies Conjugate Source Product Number Western Blot Immunofluorescnce
a-GFP Nano-Booster 488 ChromoTek ATTO 488 -- 1/200
a-Guinea Pig 647 Life Technologies A21450 1/500 1/400-1/500
a-Mouse 488 Life Technologies A11001 -- 1/400-1/500
a-Mouse 555 Life Technologies A21422 -- 1/400-1/500
a-Mouse 647 Life Technologies A21235 -- 1/400-1/500
a-Mouse HRP Promega W4028 1/2500 --
a-Mouse Pre-cleared 488 abcam ab150117 1/500 --
a-Mouse Trueblot Ultra HRP Rockland 18-8817-30 1/200 --
a-Rabbit 488 Life Technologies A11008 -- 1/400-1/500
a-Rabbit 555 Life Technologies A21428 -- 1/400-1/500
a-Rabbit 647 Life Technologies A21244 -- 1/400-1/500
a-Rabbit HRP Promega W4018 1/2500 --
a-Rat 488 Life Technologies A11006 -- 1/400-1/500
a-Rat 555 Life Technologies A21434 -- 1/400-1/500
a-Rat 647 Life Technologies A21247 -- 1/400-1/500
a-Rat HRP Pierce 31471 1/5000 --
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6.8.4 Plasmids 
6.8.4.1 Backbone Plasmids 
 
6.8.4.2 cDNA Plasmids 
 
6.8.4.3 Gateway Destination Plasmids 
 
6.8.4.4 Injection Plasmids 
 
Internal 
Reference 
Number
Plasmid Name Source
P048 pENTR/D  Bsa1 Dr. Thomas Ott
p279 pFastbac Dr. Catherine Regnard
p433 pUASp-attB This Project
Internal 
Reference 
Number
Plasmid Name Source
P069 pFastBac1-Psc-FLAG Addgene
p185 p-bsk BDGC Gold Collection
p192 p-hep BDGC Gold Collection
p215 p-Akt1-RA BDGC Gold Collection
p218 p-CDK7-RA BDGC Gold Collection
p261 p-cdc2 (CDK1) BDGC Gold Collection
p263 p-cdc2c BDGC Gold Collection
p364 pJet1 dXNP SNF2 Kinase Dead Mutant K495R Dr. Andreas Thomae
p462 p-Polo- A BDGC Gold Collection
p463 p-EGG- A BDGC Gold Collection
p464 p-mod(MDG4)-W BDGC Gold Collection
p465 p-mod(MDG4)-AA BDGC Gold Collection
p466 p-mod(MDG4)-D BDGC Gold Collection
p467 p-bon-B BDGC Gold Collection
Internal 
Reference 
Number
Plasmid Name Source
P058 pAMW Gateway Library
P079 pMT-W-FH This Project
p389 pMT-W-Myc This Project
p443 CMV-GW-GFP Dr. Gunnar Schotta
Internal 
Reference 
Number
Plasmid Name Source
p434 pUASp attB CG8290 GFP This Project
p534 p-attB hsp Psc FL WT Flag This Project
p535 p-attB hsp Psc FL T726A S729A Flag This Project
p536 p-attB hsp Psc FL T726E S729E Flag This Project
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6.8.4.5 Gateway Entry Plasmids 
 
Internal 
Reference 
Number
Plasmid Name Source
P077 pENTR/D- Psc-RA This Project
P152 pENTR/D- Psc- RA- S729(727)A This Project
P153 pENTR/D- Psc- RA- S729(727)E This Project
P154 pENTR/D- Psc- RA- T726(724)A This Project
P155 pENTR/D- Psc- RA- T726(724)E This Project
P156 pENTR/D- Psc- RA- T726(724)A/S729(727)A This Project
P157 pENTR/D- Psc- RA- T726(724)E/S729(727)E This Project
p168 pENTR/D- Psc 456-911 T726A S729A This Project
p169 PENTR/D- Psc 456-911 T726E S729E This Project
p176 pENTR/D- Psc 456-911 WT This Project
p197 pENTR/D- Psc WT 1-911 This Project
p198 PENTR/D- Psc 1-911 T726A/S729A This Project
p199 PENTR/D- Psc 1-911 T726E/S729E This Project
p222 pENTR/D- CDK7 This Project
p224 pENTR/D- Jil-1 FL Ohne CTC Dr. Catherine Regnard
p228 pENTR/D- Jil-1 FL dead mutant Dr. Catherine Regnard
p237 pENTR/D- Psc 674-783 WT This Project
p244 pENTR/D- Psc 647-783 T726E/S729E This Project
p246 pENTR/D- bsk This Project
p248 pENTR/D- hep This Project
p266 pENTR/D- Psc 1-1220 This Project
p267 pENTR/D- Psc 1-1438 This Project
p268 pENTR/D- Psc 1-1487 This Project
p288 pENTR/D- bsk T181A (dom.-neg.) This Project
p289 pENTR/D- bsk K53R (kinase-dead) This Project
p290 pENTR/D- cdc2-RA (CDK1) This Project
p291 pENTR/D- cdc2c-RA (CDK2) This Project
p298 pENTR/D- Psc Full Length T1213A/S1217A This Project
p299 pENTR/D- Psc Full Length T1213E/S1217E This Project
p310 pENTR/D- XNP This Project
p321 pENTR/D- Psc 1154-1263 Wild type This Project
p322 pENTR/D- Psc 1154-1263 T1213E/S1217E This Project
p337 pENTR/D- GFP This Project
p353 pENTR/D- Psc 1-911 C287A RING dead Mutant This Project
p354 pENTR/D- CG8290 (xPHD) Isoform A This Project
p365 pENTR/D- AKT1 F327I This Project
p460 pENTR/D- Psc 674-783 T726A/S729A This Project
p468 pENTR/D- Polo- A This Project
p469 pENTR/D- EGG- A This Project
p470 pENTR/D- mod(MDG4)-W This Project
p471 pENTR/D- mod(MDG4)-AA This Project
p472 pENTR/D- mod(MDG4)-D This Project
p473 pENTR/D- bon-B This Project
p498 pENTR/D- XNP This Project
p500 pENTR/D- XNP SNF2 Kinase Dead Mutant K495R This Project
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6.8.4.6 Expression Plasmids 
 
Internal 
Reference 
Number
Plasmid Name Source
P117 p-MT-Psc[GW-attB]-FH This Project
p180 p-MT- Psc- T726A/S729A-[GW attB]-F-hy This Project
p181 p-MT- Psc- T726E/S729E-[GW attB]-F-hy This Project
p182 p-MT- Psc 456-911 T726A/S729A-[GW attB]-F-hy This Project
p183 p-MT- Psc 456-911  T726E/S729E-[GW attB]-F-hy This Project
p184 p-MT- Psc 456-911-[GW attB]-F-hy This Project
p200 p-MT- Psc WT 1-911-[GW attB]-F-hy This Project
p201 p-MT- Psc 1-911 T726A/S729A-[GW attB]-F-hy This Project
p202 p-MT- Psc 1-911 T726E/S729E-[GW attB]-F-hy This Project
p270 p-MT-Psc 1-1220 [GW attB] F HA-hy This Project
p271 p-MT-Psc 1-1438 [GW attB] F HA-hy This Project
p272 p-MT-Psc 1-1487 [GW attB] F HA-hy This Project
p284 pFastbac-Psc-456-911-FLAG This Project
p285 pFastbac-Psc-456-911-T726A S729A-FLAG This Project
p286 pFastbac-Psc-456-911-T726E_S729E-FLAG This Project
p287 pFastbac-Cdk7-FLAG This Project
p300 pMT- Psc 674-783 WT- F-HA-Hy This Project
p301 pMT-Psc 674-783 T726E/S729E - F-HA-Hy This Project
p302 pMT-Flag-HA CG8290 (xPHD) - Hy Dr. Andreas Thomae
p305 pMT- Flag-HA dXNP (ATRX) -Hy Dr. Andreas Thomae
p311 pMT-Psc Full Length T1213A/S1217A-F-HA-Hy This Project
p312 pMT- Psc Full Length T1213E/S1217E-F-HA-Hy This Project
p316 pAct5C Myc- XNP GW This Project
p323 pMT-Psc 1154-1263 Wild type-F-HA This Project
p324 pMT Psc 1154-1263 T1213E/S1217E- F-HA This Project
p338 p-MT - GFP [GW attB] hy This Project
p366 pFastbac- AKT1- FLAG This Project
p367 pFastbac- AKT1 F327I -FLAG This Project
p372 pFastbac- bsk- FLAG This Project
p374 pFastbac-bsk K53R - FLAG This Project
p375 pMT-Psc 1-911 Ring Dead- FLAG/HA Hygromycin This Project
p461 pMT Psc 674-783 T726A/S729A This Project
p474 pMT Polo- A- Myc This Project
p475 pMT EGG- A- Myc This Project
p476 pMT mod(MDG4)-W - Myc This Project
p477 pMT mod(MDG4)-AA - Myc This Project
p478 pMT mod(MDG4)-D - Myc This Project
p479 pMT bon-B - Myc This Project
p480 pCMV CG8290 GFP This Project
p481 pFastbac-Psc-456-911-TEV-FLAG This Project
p482 pFastbac-Psc-456-911-T726A S729A-TEV-FLAG This Project
p483 pFastbac-Psc-456-911-T726E_S729E-TEV-FLAG This Project
p485 pCMV XNP GFP This Project
p505 pMT- Psc 456-911 WT- Myc This Project
P507 pFastBac- Bsk 2x TEV Flag This Project
P508 pFastBac Bsk K53R 2x TEV Flag This Project
P509 pFastBac Akt1 2xTEV Flag This Project
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Expression Plasmids Continued 
 
 
 
P509 pFastBac Akt1 2xTEV Flag This Project
Internal 
Reference 
Number
Plasmid Name Source
P510 pFastBac Akt1 F327I 2xTEV Flag This Project
P511 pFastBac CDK7 2xTEV Flag This Project
P512 pFastBac Polo 2x TEV Flag This Project
P513 pFastBac CDK9 2xTEV Flag This Project
P514 pFastBac CDK1 (cdc2) 2xTEV Flag This Project
P515 pFastBac CKA 2xTEV Flag This Project
P516 pFastBac Jil-1 FL without CTC 2xTEV Flag This Project
P517 pFastBac Jil-1 FL Dead mutant without CTC 2x TEV Flag This Project
p519 pCMV XNP GW FLAG This Project
p521 pFastBac XNP 2x TEV Flag This Project
p522 pFastBac XNP Kinase Dead 2x TEV Flag This Project
p529 pMT Bsk Myc This Project
p530 pMT Jil-1 FL Ohne CTC Myc This Project
p531 pMT CDC2 (CDK1) Myc This Project
p532 pMT CDK7 Myc This Project
p533 pMT AKT1 Myc This Project
 
M a t e r i a l s  a n d  M e t h o d s  
110 
6.8.5 Primers 
6.8.5.1 Cloning Primers 
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Cloning primers Continued 
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6.8.5.2 CRISPR Primers 
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6.8.5.3 RNAi Primers 
 
6.8.5.4 RT-qPCR Primers 
 
6.8.6 Reagents and buffers 
6.8.6.1 Kits 
 
Target Strand Sequence Features Source
Bonus F TAATACGACTCACTATAG CCATCCTCTCGAGCAAAAAG T7 Promoter This Study
Bonus R TAATACGACTCACTATAG CATATTCTGCGGATGTGTGG T7 Promoter This Study
Bonus F TAATACGACTCACTATAG GTCATTGAGCTCCTCTTCGC T7 Promoter This Study
Bonus R TAATACGACTCACTATAG GGCTTGATCGTGTGATCCTT T7 Promoter This Study
Target Strand Sequence 5'- 3' Source
297 F AGGCACCTGGTACCCGATAA This Study
297 R GGAGATATCCGTGGTTGGTGTC This Study
Roo F AGCCTCTACCAGCAGCAGAA This Study
Roo R AGCTGATGTCGTTGTTGTTGC This Study
mdg3 F GAGCCACCTGTACAGCCAAC This Study
mdg3 R CCTGGTTCACGTTTGGGCTT This Study
HeT-A F CGCGCGGAACCCATCTTCAGA Chengjian Li et al. Cell 2009
HeT-A R CGCCGCAGTCGTTTGGTGAGT Chengjian Li et al. Cell 2009
412 F CACCGGTTTGGTCGAAAG Chengjian Li et al. Cell 2009
412 R GGACATGCCTGGTATTTTGG Chengjian Li et al. Cell 2009
Act5c F GGCGCAGAGCAAGCGTGGTA Marco La Fortezza
Act5c R GGGTGCCACACGCAGCTCAT Marco La Fortezza
Tubulin F TGGGCCCGTCTGGACCACAA Marco La Fortezza
Tubulin R TCGCCGTCACCGGAGTCCAT Marco La Fortezza
RpL32 F AAGCGGCGACGCACTCTGTT Marco La Fortezza
RpL32 R GCCCAGCATACAGGCCCAAG Marco La Fortezza
RpL13 F AGCTGAACCTCTCGGGACAC Marco La Fortezza
RpL13 R TGCCTCGGACTGCCTTGTAG Marco La Fortezza
Kit Name Company Product Number
NucleoSpin Gel and PCR Clean-up Kit Macherey-Nagel 740609.25
NucleoSpin Plasmid DNA Purification Kit Macherey-Nagel 740588.25
NucleoBond Xtra Plasmid DNA Purification Kit Macherey-Nagel 740414.1
SuperScript III Reverse Transcriptase Invitrogen 11752-050
Colloidal Blue Staining Kit Invitrogen LC6025
MEGAclear Kit ambion AM1908
Gibson Assembly Master Mix BioLabs E2611S
QuantiTect Reverse Transcription Kit Qiagen 205310
Fast SYBR Green Master Mix appliedbiosystems 4385612
CloneJET PCR Cloning Kit Thermo-Scientific K1231
Gateway LR Clonase II Enzyme Mix Invitrogen 11791-020
HiScribe T7 Quick High Yield RNA Synthesis Kit New England Biolabs E2050S
Advantage cDNA Polymerase Mix Clontech 639105
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6.8.6.2 Reagents 
 
Reagent Company Product Number
2-Mercaptoethanol (BME) Sigma-Aldrich M3148
2-Propanol Roth 6752.1
4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) Sigma-Aldrich 32670
660 nm Protein Assay Reagent Pierce 22660
Agar Roth 5210.2
Agarose Sigma-Aldrich A9539
Albumin Fraction V (BSA) Roth 8076.4
Antarcitc Phosphatase New England Biolabs M0289S
Antarcitc Phosphatase 10x Buffer New England Biolabs B0289S
Bad Stabil neoLab 1-6095
Bromophenol Blue AppliChem A3640
BSA Standards Pierce 23208
cOmplete Mini Protease Inhibitor Cocktail Tablets Roche 11836153001
Copper (II) sulphate pentahydrate Sigma-Aldrich C8027
di-Sodium Phosphate Roth T877.1
Dimethyl sulfoxide (DMSO) AppliChem A3006
Dithiothreitol (DTT) Sigma-Aldrich D0632
Dulbecco's Modified Eagle Medium (DMEM) Serum Free Sigma-Aldrich D6429
ECL Western Blotting Substrate Pierce 32209
Ethanol Roth P075.1
Ethidium bromide Serva 21238.01
Ethylenediamine tetraacetic acid disodium salt dihydrate (EDTA) Roth 8043.2
Fetal Bovine Serum PAA A15-151
Flag M2 Sepharose Beads Sigma-Aldrich A2220
Glycine Roth 3187.4
HEPES Roth HN77.5
Hydrochrloric Acid Sigma-Aldrich H1758
Hydrogen Peroxide Sigma-Aldrich 216763
Hydroxyurea Sigma-Aldrich H8627
Hygromycin Sigma-Aldrich H3274-50MG
L-Glutamine PromoCell Discontinued
LB Broth Roth X968.3
Lipofectamine 3000 Thermo Fischer Scientific L3000001
Lithium chloride Sigma-Aldrich L9650
Lysine Sigma-Aldrich L5501
Meliseptol B Braun 18890
Methanol Roth CP43.4
Nitrocellulose Membrane BIO-RAD 162-0115
Normal Goat Serum (NGS) BIOZOL VEC-S-1000-CE
NP-40 (Tergitol solution) Sigma-Aldrich NP40S
OptiMEM Thermo Fischer Scientific 31985070
PageRuler Plus Prestained Protein Ladder Thermo Fischer Scientific 26619
Paraformaldehyde (PFA) 16% Electron Microscopy Sciences 15710
Paraformaldehyde (PFA) 32% Electron Microscopy Sciences 15714
PBS tablets Sigma-Aldrich P4417
Penicillin-Streptomycin Sigma-Aldrich P4333
Phalloidin-Tetramethyrhodamine B isothiocyanate Sigma-Aldrich P1951
Phenol/Chloroform Roth A156.1
Phenylmethanesulfonyl fluoride (PMSF) Sigma-Aldrich P7626
PhosSTOP Phosphatase Inhibitor Cocktail Tablets Roche 04906837001
Potassium Chloride Roth 6781.1
Powdered Milk Roth T145.2
Protein G Sepharose Beads GE Healthcare 17-0618-01
RNAlater RNA Stabilization Reagent Qiagen 1017980
Rotiphorese Gel 30 (37.5:1) Acrylamide Roth 3029.1
Schneiders Drosophila Medium Serum Free Media AMIMED 1-43F00-I
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Schneiders Drosophila Medium Serum Free Media AMIMED 1-43F00-I
Reagent Company Product Number
SDS Pellets Roth CN30.3
Sf900™ II Serum Free Media Thermo Fischer Scientific 10902-088
Silver Nitrate Sigma-Aldrich S6506
SlowFade Gold Antifade reagent Life Technologies S36936
Smart Ladder Short Fragment Eurogentec MW-1800-04
Sodium Azide Sigma-Aldrich S8032
Sodium bicarbonate Sigma-Aldrich S-6014
Sodium Chloride AppliChem 4I017481
Sodium Orthovanadate Sigma-Aldrich 450243
T7 endonuclease New England Biolabs M0302
Tetramethylethylendiamin (TEMED) Roth 2367.3
TRIS Roth 2449.3
Triton X-100 Sigma-Aldrich T8787
TRIzol ambion 15596026
Trypsin Sigma-Aldrich T4174
TURBO DNA-free ambion 1406057
Tween 20 Roth 9127.1
Urea Roth 2317.1
X-tremeGENE HP DNA Transfection Reagent Roche 06366236001
 
M a t e r i a l s  a n d  M e t h o d s  
116 
6.8.6.3 Buffers 
 
 
Buffer Component
S2 Cell Lysis Buffer 20 mM Tris-HCl pH 7.5
150 mM NaCl
1 mM EDTA
0.5% Triton X-100
10 mM PMSF -Added Fresh
cOmplete mini protease inhibitor cocktail - Added Fresh
PhosSTOP phosphatase inhibitor - Added Fresh *
XX mM Sodium Orthovanadate - Added Fresh *
Sf21 Cell Lysis Buffer 25 mM HEPES pH 7.6
5% Glycerol
0.5 mM EDTA
300 mM KCl
3 mM MgCl2
0.1% NP-40
1 mM DTT - Added Fresh
cOmplete mini protease inhibitor cocktail - Added Fresh
PhosSTOP phosphatase inhibitor - Added Fresh *
XX mM Sodium Orthovanadate - Added Fresh *
TBS (10 x) 200 mM Tris-HCl
1.5 M NaCl
Distilled water
Adujst pH to 7.5 with HCl
Wet Blot Transfer Buffer 10% 10 x Wet Blot Buffer
20% Methanol
Water
Wet Blot Buffer (10 x) 1.92 M Glycine
250 mM Tris-HCl
Water
TBST 1 x TBS
0.05% Tween-20
Laemmli Buffer (4 x) 2% SDS
10% Glycerol
60 mM Tris-HCl
0.02% Bromophenolblue-sodium-salt
1.25% BME
200 mM DTT
Bead Blocking Solution 2 g BSA
100 ml TBS (1 x)
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6.8.7 Equipment 
6.8.7.1 Microscope Equipment 
 
Buffer Component
Membrane Blocking Solution 3 g BSA
100 ml TBST
Tissue Blocking Solution 500 ul NGS
9.5 ml 0.1-0.5% PBST
PBST 1 PBS Tablet 
200 ml Water
Triton X-100 to final concentration
SDS Buffer (10 x) 3.5 mM SDS
25 mM Tris-HCl
1.92 M Glycine
Water
PBL 1 mM Lysine-HCl
12 mM Disodium Phosphate
PBS (1 x)
A+NP Nuclear Extraction Buffer 15 mM NaCl
15 mM Tris-HCl pH 8.0
13 mM EDTA
60 mM KCl
0.5% NP-40
0.1% BME
10 mM PMSF -Added Fresh
cOmplete mini protease inhibitor cocktail - Added Fresh
PhosSTOP phosphatase inhibitor - Added Fresh *
Microscope Equiptment Company
Confocal Laser Scanning Microscope TCS Sp5 Leica
Diode Laser 405 nm, 25 mV Leica
Argon Laser 458, 476, 488 and 514 nm Leica
DPSS Laser 561 nm, 10 mV Leica
HeNe Laser 633 nm, 10 mV Leica
HCX PL APO Lambda Blue 20x 0.7 imm Leica
HCX PL APO Lambda Blue 63x 1.4 oil Leica
Immersion oil 518F Carl Zeiss
Software:  Leica Application Suite Leica
Stereoscopic Zoom Microscope SMZ745 Nikon
KL 1500 LCD with flexible light guides Schott AG
Halogen lamp 15V/150W, Type 6423FO Phillips
Fluorescence  Stereomicroscope StereoLumar v12 Carl Zeiss
Neolumar S 0.8x FWD 80mm, PI 10x/23 eyepieces Carl Zeiss
Filters:  38 HeGFP BP470/40, BP525/50 Carl Zeiss
43 Cy3 BP545/25, BP605/70 Carl Zeiss
Lightsource:  HXP 120 C Carl Zeiss
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6.8.7.2 Consumables 
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General Equiptment and Consumables Company
Scepter™ 2.0 Cell Counter Millipore
Scepter™ 2.0 Cell Counter Sensors Millipore
Typhoon Scanner GE Healthcare
ChemiDoc BioRad
CryoPure Tubes Starstedt
TC Flask T75, Cell+ Starstedt
TC Flask T25, Cell+ Starstedt
TC Plate, 6 well, Cell+, F Starstedt
5 ml Pipetman tips Starstedt
10 ml Pipetman tips Starstedt
25 ml Pipetman tips Starstedt
Parafilm Parafilm
Cell Scraper 25 cm Starstedt
Erylenmyer Flask with vented cap (100 ml ) Corning
Erylenmyer Flask with vented cap (1000 ml ) Corning
Tube (15 ml) Starstedt
Tube (50 ml) Starstedt
Microplate, 96 Well, PS, F-Bottom Bio-one
Mini-PROTEAN Western Blot System BioRad
Tissue Culture dish 100 x 20 mm Falcon
ibidi 8 well slides ibidi
Cover Slips 18 x 18 Menzel-Gläser
Microscope Slides SuperFrost White Roth
Omnifix-F 1ml syringe B Braun
Sterican 27 G Needle B Braun
Sterican 21 G Needle B Braun
S2 Cell Culture Incubator Binder
Sf21 Cell Culture Incubator Infors HT Multitron
HELA Cell Incubator Binder
Filtropur S 0.45 um Starstedt
Filtropur S 0.2 um Starstedt
Äkta purifier Amersham Biosciences
96 Well qPCR plates Starstedt
SafeSeal Tube 1.5 ml Starstedt
SafeSeal Tube 0.5 ml Starstedt
SafeSeal Tube 2.0 ml Starstedt
Chromotography Paper, type MN260 Roth
Biosphere Fil.Tip 20 ul Starstedt
Biosphere Fil.Tip 200 ul Starstedt
Biosphere Fil.Tip 1000 ul Starstedt
Pipette Tip 200 ul Starstedt
Pipette Tip 1000 ul Starstedt
Pipette Tip 20 ul Starstedt
Nitrile Lite Examination Gloves (M) VWR
Filtropur V25 0.2 um, 250 ml Starstedt
Fine forceps Fine Science Tool
Immersion oil 518F Carl Zeiss
Agilent 2100 Bioanalyzer Agilent Technologies
CFX96 Real-Time PCR Detection System Bio-Rad 
Incubator (18 °C), Percival CLF Plant Climatics
Incubator (25°C), Mir-154 Panasonic Biomedical
Nutating Mixer VWR
Vortex mixer Scientific Industries
Water bath Julabo
Power Scanner TECAN
Superdex 200 10/300 GL GE Healthcare
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6.8.7.3 Software 
 
Software Company
Adobe Illustrator CS5.1 Adobe Systems
Adobe Photoshop CS5.1 Adobe Systems
Image J1.48 b Wayne Rasband, National Institues of Health
Office 2008, 2016 Microsoft
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Abbreviations 
 
Abreviation Long form
ADD ATRX-DNMT3-DNMT3L domain
ATRX Alpha-thalasemia mental retardation X-linked
BLAST Basic local alignment search tool
Bon Bonus
BSA Bovine serum albumin
cDNA complementary DNA
ChIP Chromatin immunoprecipitation
chro chromator
CuSO4 Copper sulphate
DAPI 4`, 6-diamidino-2-phenylindole
El. Elution
FL Full length
gDNA genomic DNA
GFP/RFP Green/red fluorescent protein
Gnf1 Germ line transcription factor 1
GW Gateway
H2Av Histone 2A variant
H3K4 Histone 3 Lysine 4
H3K4me3 Histone 3 Lysine 4 tri-methylation
H3K9 Histone 3 Lysine 9
H3K9me3 Histone 3 Lysine 9 tri-methylation
HA Hemagglutinin
HP1 Heterochromatin protein 1
HP1a Heterochromatin protein 1 a
HP1b Heterochromatin protein 1 b
In. Input
IP Immuno-precipitation
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IP Immuno-precipitation
Abreviation Long form
kD Kilo-dalton
LC-MS/MS Liquid Crystal- Mass Spectroscopy/Mass Spectroscopy
LMG Lemming
MAPK Mitogen activated protein kinase
MS Mass Spectroscopy
NGS Normal goat serum
O-GlcNAc O-linked N-acetylglucosamine 
PAR Poly-(ADP Ribose)
pMT Metallothionine Promoter
Prod Protein proliferation disrupter 
PTM Post translational modification
Pzg putzig
RT-qPCR Real time- quantitative PCR
SDS Sodium dodecyl sulfate
TTC Trials to criterion
upd Unpaird ligand
UTR Untranslated region
WT Wild type
y-H2Av Phosphorylated Histone 2A variant
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7 Supplementary Materials 
Table 4: dADD1 specific interactors with log2 iBAQ (dADD1/S2 control) greater than 3 and P-Value 
less than 0.06. 
 
 
Gene Name FB ID
ID Volcano 
Plot
Log2 
dADD1/Control
P-Value
prod FBgn0014269 270 12.02 1.53E-03
Hsp60 FBgn0015245 8 11.37 6.06E-11
Eb1 FBgn0027066 230 11.19 1.07E-07
Chro FBgn0044324 294 10.74 6.74E-04
Vps29 FBgn0031310 398 10.33 6.91E-10
CG15107 FBgn0041702 220 9.59 4.88E-04
RpL21 FBgn0032987 336 9.32 2.75E-11
Hsc70-5 FBgn0001220 76 8.80 5.51E-07
ncd FBgn0002924 60 8.52 5.40E-03
deltaCOP FBgn0028969 456 8.09 2.15E-03
Jra FBgn0001291 58 8.03 6.22E-03
beta'COP FBgn0025724 19 7.85 1.21E-03
Sep2 FBgn0014029 106 7.76 3.67E-09
gammaCOP FBgn0028968 143 7.57 7.62E-11
AnxB9 FBgn0000083 63 7.34 3.43E-09
cg FBgn0000289 244 7.25 1.90E-02
26-29-p FBgn0250848 326 7.21 8.91E-03
CG4552 FBgn0031304 397 7.16 6.66E-10
RpII33 FBgn0026373 263 6.86 2.57E-03
Rpt1 FBgn0028687 288 6.33 2.24E-02
Dap160 FBgn0023388 253 6.31 1.09E-04
Ranbp9 FBgn0037894 358 6.27 1.14E-07
RpS5a FBgn0002590 124 6.26 9.25E-08
Cdc5 FBgn0265574 439 5.95 2.55E-03
epsilonCOP FBgn0027496 459 5.86 5.00E-02
Sep1 FBgn0011710 90 5.86 4.22E-09
woc FBgn0010328 248 5.56 9.24E-08
thoc5 FBgn0034939 204 5.56 3.90E-09
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Table 4 Continued 
 
 
thoc5 FBgn0034939 204 5.56 3.90E-09
Gene Name FB ID
ID Volcano 
Plot
Log2 
dADD1/Control
P-Value
pod1 FBgn0029903 250 5.51 3.19E-07
CG4038 FBgn0011824 140 5.49 5.03E-02
Nsf2 FBgn0266464 105 5.47 1.25E-02
kz FBgn0001330 16 5.25 1.99E-06
Prp31 FBgn0036487 412 5.03 4.99E-02
HIPP1 FBgn0037027 392 5.00 6.57E-04
Deaf1 FBgn0013799 123 4.94 5.11E-02
E(bx) FBgn0000541 203 4.88 3.95E-09
CG32549 FBgn0052549 420 4.72 5.87E-09
Dhx15 FBgn0033160 281 4.64 2.73E-02
SelD FBgn0261270 12 4.53 4.98E-02
Usp7 FBgn0030366 201 4.33 1.72E-09
betaCop FBgn0008635 91 4.12 5.00E-02
Act5C FBgn0000042 45 4.11 1.17E-03
Zasp52 FBgn0265991 3 4.11 3.40E-07
CG9246 FBgn0032925 184 4.11 3.04E-07
fl(2)d FBgn0000662 215 4.09 4.98E-02
bon FBgn0023097 223 4.06 5.05E-02
Klp10A FBgn0030268 157 3.99 4.98E-02
mip130 FBgn0023509 455 3.98 5.00E-02
Hsc70-3 FBgn0001218 75 3.75 1.51E-03
Pen FBgn0267727 103 3.66 5.10E-02
Nup358 FBgn0039302 217 3.38 2.50E-02
Mat89Ba FBgn0261286 144 3.22 5.00E-02
MBD-R2 FBgn0038016 357 3.09 5.10E-02
Spt6 FBgn0028982 209 3.01 5.81E-02
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Table 5: XNP specific interactors with log2 iBAQ (XNP/S2 control) greater than 3 and P-Value less 
than 0.06. 
 
 
Gene Name FB ID ID Volcano Plot
Log2 
XNP/Control
P-Value
clu FBgn0034087 5 14.70 8.95E-12
RpL11 FBgn0013325 94 12.29 2.63E-03
Su(var)2-10 FBgn0003612 232 11.95 4.97E-12
CG43736 FBgn0263993 260 11.91 7.06E-12
CG9253-RA FBgn0032919 369 11.39 1.10E-08
tsr FBgn0011726 92 10.86 3.49E-03
CHIP FBgn0027052 457 10.64 5.67E-08
NHP2 FBgn0029148 169 10.26 8.31E-09
CG8036 FBgn0037607 365 9.93 4.92E-04
Nop60B FBgn0259937 14 9.66 3.94E-03
Bin1 FBgn0024491 177 9.66 2.27E-06
SmD3 FBgn0023167 15 9.62 5.89E-12
Cct5 FBgn0010621 285 9.38 5.63E-03
RpL7A FBgn0014026 95 9.32 8.82E-08
CG4164 FBgn0031256 396 9.30 6.08E-07
Rbm13 FBgn0030067 450 9.12 1.44E-03
msn FBgn0010909 435 9.07 4.31E-09
CG7637 FBgn0033548 171 9.02 2.45E-06
Aldh FBgn0012036 382 8.94 5.47E-03
RpL13 FBgn0011272 88 8.87 4.17E-11
RpS15Aa FBgn0010198 96 8.57 9.34E-03
Sry-delta FBgn0003512 36 8.57 5.92E-06
REG FBgn0029133 324 8.46 9.12E-03
Tcp-1eta FBgn0037632 364 8.44 1.47E-07
CkIIbeta FBgn0000259 39 8.32 5.66E-02
PCNA FBgn0005655 56 8.15 2.32E-10
nudC FBgn0021768 413 7.89 5.59E-03
CG2063 FBgn0033400 278 7.86 1.12E-14
CG17078-RA FBgn0086855 395 7.83 4.56E-03
RfC3 FBgn0032244 381 7.83 9.53E-03
U3-55K FBgn0053505 304 7.76 1.12E-07
eIF-2alpha FBgn0261609 89 7.73 2.98E-02
abs FBgn0015331 165 7.60 7.43E-03
TER94 FBgn0261014 137 7.58 1.34E-02
Art1 FBgn0037834 359 7.52 5.01E-07
mbf1 FBgn0262732 257 7.51 9.44E-09
CG5641 FBgn0038046 179 7.14 4.60E-10
Hsp70Bbb FBgn0051354 145 7.14 3.65E-02
mbm FBgn0086912 394 7.04 1.04E-07
Arpc4 FBgn0031781 384 6.99 3.91E-09
mod FBgn0002780 51 6.94 3.29E-07
Saf-B FBgn0039229 297 6.86 2.83E-05
Nopp140 FBgn0037137 258 6.85 1.42E-06
CG3817 FBgn0038275 178 6.80 1.67E-08
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Table 7 Continued 
 
 
CG3817 FBgn0038275 178 6.80 1.67E-08
Gene Name FB ID ID Volcano Plot
Log2 
XNP/Control
P-Value
Ubqn FBgn0031057 417 6.49 1.35E-02
MEP-1 FBgn0035357 264 6.42 3.14E-03
Su(fu) FBgn0005355 355 6.41 5.48E-08
PIP4K FBgn0039924 306 6.20 5.08E-02
gfzf FBgn0250732 269 6.16 1.03E-02
CG3163 FBgn0034961 442 6.14 1.73E-07
Zn72D FBgn0263603 292 5.99 3.51E-10
Rad23 FBgn0026777 328 5.98 1.29E-02
Mi-2 FBgn0262519 23 5.82 6.19E-03
simj FBgn0010762 256 5.69 5.89E-11
CG5787 FBgn0032454 377 5.66 1.31E-02
Aats-asn FBgn0086443 332 5.62 1.01E-02
Dbp73D FBgn0004556 70 5.45 3.37E-04
MTA1-like FBgn0027951 221 5.44 1.10E-06
Tep4 FBgn0041180 255 5.34 6.62E-11
Past1 FBgn0016693 312 5.32 5.90E-07
Uba1 FBgn0023143 310 5.26 2.01E-02
l(2)34Fd FBgn0261535 323 5.24 1.99E-06
Akap200 FBgn0027932 293 5.20 5.04E-02
CG18592 FBgn0031678 385 5.10 1.21E-06
RpI135 FBgn0003278 59 5.09 5.22E-05
CG1440 FBgn0030038 462 5.04 2.48E-07
RpS19a FBgn0010412 84 5.02 5.59E-02
grsm FBgn0040493 227 5.00 5.12E-02
Mlf FBgn0034051 163 4.95 4.99E-02
CG6316 FBgn0052075 308 4.86 5.00E-02
CG12909 FBgn0033507 276 4.86 5.17E-02
CG40045 FBgn0058045 307 4.81 5.00E-02
Rpt4 FBgn0028685 410 4.75 5.13E-02
CG9281 FBgn0030672 427 4.66 5.01E-02
Dpit47 FBgn0266518 229 4.57 5.11E-02
jim FBgn0027339 259 4.54 4.99E-02
CG1677-RB FBgn0029941 453 4.54 6.31E-10
RpI1 FBgn0019938 114 4.53 2.47E-03
Pdi FBgn0014002 108 4.46 4.40E-02
Prosalpha4 FBgn0004066 65 4.41 5.00E-02
RpS18 FBgn0010411 87 4.35 5.00E-02
Rpb5 FBgn0033571 273 4.34 5.65E-02
RpL18 FBgn0035753 193 4.30 5.09E-02
Mtap FBgn0034215 173 4.29 5.00E-02
hng1 FBgn0034599 447 3.98 4.99E-02
Irbp FBgn0011774 121 3.89 4.98E-02
Vps4 FBgn0027605 460 3.85 4.99E-02
CG1091 FBgn0037470 224 3.84 5.07E-02
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Table 7 Continued 
 
 
 
CG1091 FBgn0037470 224 3.84 5.07E-02
Gene Name FB ID ID Volcano Plot
Log2 
XNP/Control
P-Value
CG32409 FBgn0052409 296 3.79 5.03E-02
AnxB10 FBgn0000084 64 3.74 5.06E-02
Syp FBgn0038826 225 3.71 5.42E-02
Aatf FBgn0031851 189 3.70 5.32E-02
CG12007 FBgn0037293 388 3.40 5.12E-02
CG8545-RA FBgn0033741 239 3.40 5.33E-02
Dlic FBgn0030276 432 3.24 4.99E-02
CG3909 FBgn0027524 458 3.22 5.43E-02
Chd3 FBgn0023395 9 3.15 5.06E-02
nito FBgn0027548 287 3.12 5.00E-02
Top1 FBgn0004924 77 3.03 4.99E-02
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Table 6: Shared interactors of dADD1 and XNP with log2 greater than 3 and P-Value less than 0.06 
listed in alphabetical order. 
 
Gene Name
Log2 
dADD1/Control
P-Value 
dADD1
Log2 
XNP/Control
P-Value XNP
14-3-3epsilon 6.51 2.06E-05 6.80 1.60E-05
14-3-3zeta 7.88 1.79E-02 7.72 1.95E-02
alphaCOP 8.34 2.19E-03 3.89 5.45E-02
alphaTub84D 5.51 1.76E-04 4.65 4.50E-04
betaTub56D 6.36 1.96E-03 6.26 2.13E-03
betaTub60D 7.20 4.33E-03 7.08 4.70E-03
betaTub97EF 7.79 4.52E-03 6.74 8.84E-03
blanks 9.92 3.93E-04 9.88 4.02E-04
blw 7.75 6.42E-07 7.13 1.06E-06
CaBP1 5.89 4.15E-02 5.31 5.86E-02
Caf1 5.33 5.14E-02 10.36 3.29E-03
capt 10.93 2.98E-10 10.85 3.11E-10
Cctgamma 6.67 2.72E-07 8.33 7.20E-08
CG10139 10.17 1.52E-05 8.29 4.91E-05
CG11999 6.52 7.97E-03 7.39 4.46E-03
CG1316 9.60 1.00E-07 7.96 3.08E-07
CG15784 5.19 5.05E-02 9.27 4.77E-03
CG2199 7.74 1.83E-04 8.72 9.35E-05
CG2691 4.34 1.46E-05 4.31 1.54E-05
CG2982 7.78 1.55E-08 8.05 1.26E-08
CG3335 7.58 1.64E-06 7.74 1.45E-06
CG4747 10.62 7.65E-08 10.53 8.07E-08
CG5168 8.39 4.10E-08 7.00 1.21E-07
CG5525 6.67 1.33E-07 7.51 6.53E-08
CG6937 7.83 9.09E-06 7.01 1.74E-05
CG7033 6.44 3.60E-05 8.85 5.68E-06
CG7946 7.65 9.13E-07 7.36 1.15E-06
CG8258 4.90 5.11E-02 8.65 5.16E-03
CG8414 4.30 4.42E-05 5.58 9.71E-06
cher 8.49 1.63E-04 5.58 1.56E-03
chic 13.32 3.21E-03 6.89 4.99E-02
CkIIalpha 6.27 1.49E-04 14.49 1.16E-06
Dp1 11.08 3.07E-04 3.65 4.99E-02
dre4 7.95 2.27E-03 7.11 3.92E-03
Droj2 11.80 6.12E-08 12.06 5.38E-08
Ef1alpha48D 8.41 1.22E-02 7.88 1.60E-02
Ef1gamma 5.03 5.23E-02 7.62 1.06E-02
EF2 9.28 2.02E-05 11.18 6.86E-06
eIF-4a 7.65 1.19E-03 7.88 1.03E-03
eIF4G 7.45 2.97E-09 5.86 1.25E-08
Fib 10.29 4.57E-04 8.64 1.16E-03
FK506-bp1 11.99 6.44E-10 13.96 2.58E-10
Fmr1 6.59 1.11E-03 7.01 8.03E-04
Gfat2 8.74 2.11E-05 7.36 5.65E-05
Gnf1 7.19 3.52E-06 8.32 1.48E-06
Got1 5.60 5.68E-02 6.48 3.44E-02
Hel25E 4.42 5.06E-02 6.71 1.01E-02
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